1.1.16 master CV

1 05/07/16
K.V. CHALAM, MD, PhD, MBA, FACS.
Curriculum Vitae
INDEX Page No.
1. Biodata 2
2. Current Position 2-3
3. Academic Qualifications 4
4. Membership 7
5. Honors & Awards 8-15
6. Bibliography 15- 80

2 05/07/16
K.V. CHALAM, MD, PhD, MBA, FACS
Curriculum Vitae
DATE OF BIRTH August 1, 1959
MARITAL STATUS Married
CITIZENSHIP United States
BUSINESS ADDRESS Department of Ophthalmology
580 W 8th Street
Jacksonville, FL 32209.
Tel No. 904-403-2607 / 244-9361
Fax No.904-244-9391
HOME ADDRESS 10053 Lakes End Court
Jacksonville, FL 32256.
Tel No. 904-403-2607 / 519-2949
Fax No.904- 519-2949
E-mail.kvchalam@aol.com ; kchalam@jax.ufl.edu
PRESENT ACADEMIC POSITION 1. Chairman and Tenured Professor
Department of Ophthalmology
University of Florida College of Medicine
Jacksonville, Florida
2. Associate Dean
Veterans Administration Affairs
3. Program Director
Residency Education
Fellowship Education
4. Chief, Ophthalmology Service

3 05/07/16
UF Health Hospital
4. Director, Vitreoretinal Service
Neuroophthalmology service
Electrophysiology Service
Uveitis and Ocular Oncology Service
University of Florida College ofMedicine, Jacksonville, Florida
PREVIOUS POSITION 1. Associate Chairman and Associate Professor
2. ResidencyProgram Director
Residency education
USC School of Medicine
Columbia, South Carolina
2. Associate Professor
USC School of Medicine
3. Attending ophthalmologist
Richland Memorial Hospital
DornJennings Veterans Administration Hospital
HealthSouth Hospital
Providence Hospital
4. Director, Vitreoretinal Service
Neuroophthalmology service
Electrophysiology Service

4 05/07/16
USC School of Medicine,
ACADEMIC APPOINTMENTS / POSITIONS:
2006-Present Tenured Professor and Chairman
2004-Present Basic Science Research Professor
Department of Microbiology and Pathology
USC School of Medicine, Columbia, South Carolina
2000-2005 Associate Professor and Associate Chairman
1998-99 Associate Professor
USC School of Medicine, Columbia, South Carolina
1994-98 Assistant Professor
USC School of Medicine. Columbia, South Carolina
1997-Present Visiting Lecturer
Harvard Medical School, Boston, Massachusetts
1993-94 Instructor
UT Southwestern Medical School. Dallas, Texas
1992-93 Assistant Instructor

5 05/07/16
UT Southwestern Medical School. Dallas, Texas
POSTGRADUATE QUALIFICATIONS:
Earned
ABO Certification Diplomat, American Board of Ophthalmology
Nov.1993/2003/2013. Valid until 2024
Ph. D (Molecular Biology) University of South Carolina
Visual Science, Biomedical Sciences Graduate Program
Columbia, South Carolina. May O4 / 3.63 / 4.00 GPA
M.B.A Webster University
St.Louis, Missouri. October 99 / 3.90 / 4.00 GPA
F.R.C.S.C (Ophthalmology) Fellow, Royal College ofPhysicians and Surgeons
CANADA. November 90
F.R.C. Ophth. Fellow, Royal College ofOphthalmologists
London, ENGLAND. November 90.
F.R.C.S (Ophthalmology) Fellow, Royal College ofSurgeons ofEdinburgh. Edinburgh,
ENGLAND. November 84.
D.O.R.C.S (Ophthalmology) Diplomat, Royal College of Surgeons
IRELAND. October 84.
M.S. (Ophthalmology) PostGraduate Institute of Medical Education and Research, Chandigarh,
INDIA. January 83.
Admitted
F.A.C.S Fellow, AmericanCollege of Surgeons
Ophthalmology, 1996

6 05/07/16
F.I.C.S Fellow, International College of Surgeons
USA Section, 1996
GRADUATE EDUCATION:
M.D. University of State of New York
Albany, New York. June 92
M.B.B.S GunturMedicalSchool
Guntur, INDIA. October 72- October 78
I.S. Andhra Loyola College
Vijayawada. India. July 70- June 72
POSTGRADUATE CLINICAL TRAINING:
FELLOWSHIP:
Vitreo-retinal Surgery UT Southwestern Medical School, Dallas
July 92 -June 94.
Chairman: Dr. J. McCulley.
Preceptor. Dr. R. Anand / Dr. C. Wilson.
Neuroophthalmology UT Medical School at Houston
July 87 - June 88.
Chairman: Dr. R. Ruiz.
Preceptor: Dr. R. Tang.
Ocular Oncology MD Anderson Cancer Center, Houston
Department of Ophthalmology / Head and Neck Surgery
July 87 - June 88.
Chairman: Dr. H.Goepffert.
Preceptor: Dr. R. Tang

7 05/07/16
RESIDENCY & INTERNSHIP:
Ophthalmology Catholic Medical Center
(Residency) Affiliate. Cornell University Medical School
New York. July 89- June 92.
Chairman: Dr. David Paton
General Surgery Catholic Medical Center
(Internship) Affiliate. Cornell University Medical School
New York. July 88- June 89.
Chairman: Dr. Walter Pizzi
Instructor Department of Ophthalmology
Ipswich Hospital, Ipswich, ENGLAND
May 85- June 87
Chairman: Dr. M. J. Parkinson
Senior Resident Prince Charles Eye Unit.
Ophthalmology King Edward VII Hospital, Windsor. ENGLAND.
March 84 - April 85
Chairman: Dr. J.J. Kanski.
Teaching fellow Post Graduate Medical Institute
Ophthalmology Chandigarh, INDIA.
January 80 - March 83
INTERNSHIP Guntur General Hospital. Guntur, India.
Transitional October 78- December 79
LICENSURE:
South Carolina July 94/ 17105
Florida Jan.97/ 72613
New York Jan. 89/ 176948
Texas July.92 / J-1634

8 05/07/16
ECFMG Jan 79/ 307-821-9
USLME Sept. 83/ 307-821-9
FLEX Dec. 86/ I.D. NO. 550801024
Eligible for licensure in all states
United Kingdom April 84/ 121346
NATIONAL AND INTERNATIONAL SPECIALTY BOARD CERTIFICATION:
 Diplomat, American Board of Ophthalmology, November.1993. Recertified 2003, 2013
 Royal college of Physicians and Surgeons of Canada, November.1990
 Royal College of Ophthalmologists, United Kingdom, July.1990
 RoyalCollege of Surgeons, Edinburgh, United Kingdom, November.1984
 Royal college of Physicians and Surgeons, Ireland, August.1984
 Certificate in specialist surgical training, Royal Academy of Medicine, London, January.1998
MEMBERSHIP, PROFESSIONAL SOCIETIES AND LEARNED SCIENTIFIC BODIES:
Fellow / American College of Surgeons (FACS)
Fellow / American Academy of Ophthalmology
Fellow / Association for Research and Vision in Ophthalmology
Member, American Society of Retinal Specialists
Member, American Association for Advancement of Science
Member, Association of Biomedical Engineers
Member, International Society for Stem Cell Research
Member/ Association of University Professors in Ophthalmology
Member/ American Association of University Professors
Member, Medical Group Management Association
Member, American Medical Association, Southern Medical Association
Member/Canadian Ophthalmological Society
Fellow/American Society of Cataract and Refractive Surgeons
Fellow, RoyalCollege of Ophthalmologists, England
Fellow, RoyalCollege of Surgeons, Canada
Fellow, Royal College Surgeons, Edinburgh
Member, Florida Ophthalmological Society

9 05/07/16
Member, Florida Medical Association
Member, All India Ophthalmological society
Member, North American Neuro-ophthalmology Society
Member, Uveitis Society
Member, Ophthalmic Echographers Association
Member, Sigma XI Science Society
Member, American Medical Writers Association
Member, International Society for Ocular Pharmacology and Toxicology
HONORS & AWARDS:
 “University of Florida Research Foundation Professor” awarded by University of Florida for
outstanding research contributions 2015-2018
 “Jackonville Health Care Hero” awarded by Jackonville Business Journal for outstanding
contributions to community of Jacksonville 2015
 “Senior Achievement Award” for outstanding program service to American Academy of
Ophthalmology. 2010
 “Outstanding Alumni Award for 2012” from University of South Carolina School of Medicine for
outstanding research and scholarly contributions
 “Deans Research / Scholar Award” for outstanding research and scholarly contributions during 2004-
05 Academic Year
 “Senior Honor Award” for outstanding program service to American Society of Retinal Specialists.
2005
 “Director, Top Research Site award from National Institute of Health-Diabetic Retinopathy
Clinical Research Network” for year 2008 (1/202 investigative sites)
 “Director, Top Site award for R protocol Recruitment” from National Institute of Health-Diabetic
Retinopathy Clinical Research Network” (1/202 investigative sites)
 “Medical Director, O Protocol” National Institute of Health-Diabetic Retinopathy Clinical
Research Network
 “Member, Executive Committee” Diabetic retinopathy Clinical Research Network, National Eye
Institute.
 Chair, Basic and Clinical Science Course Volume 2, American Academy of Ophthalmology,
Continuing Medical Education Division, 2005-2010
 Secretary-Treasurer, International Society of Ocular Toxicology and Pharmacology, 2005-2013

10 05/07/16
 “Best Teacher of the year” academic years 1995 and 1996, Department of Ophthalmology, USC
School of Medicine, Columbia, South Carolina.
 “Achievement Honor Award” for outstanding program service to American Academy of
Ophthalmology. 2000
 “Honor Award” for outstanding program service to American Society of Retinal Specialists. 2004
 “Member, Steering Committee” Diabetic retinopathy Clinical Research Network, National Eye
Institute.
 “Chancellor List” for outstanding graduate work at University of South Carolina, 2005
 “Certificate of Appreciation” for outstanding program service to American Board of Ophthalmology.
1997 and 2007
 “Certificate of Appreciation” for outstanding program service to National Eye Care Project of
American academy of Ophthalmology. 2001
 “Who is Who in World” Marquis Who’s Who Publication 2000-Present
 “Who is Who in America” Marquis Who’s Who Publication 2000- Present
 Associate Examiner, American Board of Ophthalmology, 1995 – Present
 “Who is Who in Science and Engineering” Marquis Who’s Who Publication 2000- Present
 “Who is Who in Finance and Industry” Marquis Who’s Who Publication 2000- Present
 “Who is Who in America” Strathmore’s Who’s Who Publication 2000-2001
 “Who is Who in Science and Engineering” Strathmore’s Who’s Who Publication 2000-2001
 “Who is Who in Science and Engineering” Lexington’s Who’s Who Publication 2000-2001
 Score of 99 in written qualifying examination of American Board of Ophthalmology, 1993.
 “2000 Outstanding Scholars of 21st Century” International Biographic Institute Publication 2000-
2001
 OKAP Score of 99 for three consecutive years during residency training, 1989 - 92
 Chief Resident, Catholic Medical Center, Department of Ophthalmology 1991 - 92
 Annual Residents Day Research Award, Catholic Medical Center, 1990, 91 & 92
 FIRST RANK in Master of Surgery (Ophthalmology) Examination, 1983, India
 Honors and Distinction In ANATOMY 6/75
 Honors and Distinction In PHYSIOLOGY 6/75
 Honors and Distinction In BIOCHEMISTRY 6/75
 Honors and Distinction In PHARMOCOLOGY 6/76
 Honors and Distinction In PATHOLOGY 6/77
 Honors and Distinction In MICROBIOLOGY 6/77

11 05/07/16
 Honors and Distinction In PUBLIC HEALTH 12/77
 Honors and Distinction In GENERAL MEDICINE 8/78
 Honors and Distinction In GENERAL SURGERY 8/78
 Class standing 2/152 in Medical School, 10/78
 College Scholarships, Medical College, Guntur, 1972 - 78
 National Science Talent Search Scholarship, National Council for Educational Research and Training,
Govt. of India, 1970
 National Scholarship, Ministry of Education and Youth Services, Government of India, 1970
 Ranked first in the state Higher secondary examination, 1970
COMMITTEE APPOINTMENTS:
2004-2010 Chairman, Basic and Clinical Science Course Review Committee, Continuing
Medical Education Division, American Academy of Ophthalmology
2000-present Member, Online Continuing Medical Education Committee, American Academy of
Ophthalmology
2000-present Program Director, Residency and Fellowship Education, Department of
Ophthalmology, Shands Jacksonville Hospital, Jacksonville, Florida
2000-present Chief, Department of Ophthalmology, Shands Jacksonville Hospital, Jacksonville,
Florida
2000-present Chief Compliance Officer, Department of Ophthalmology, Shands Jacksonville
Hospital, Jacksonville, Florida
2000-present Member, University of Florida Finance Committee, Jacksonville, Florida
2004-present Member, Institutional Review Board, University of Florida College of Medicine,
Jacksonville Campus, Florida
2000-present Member, Board of Directors, University of Florida Jacksonville Health Sciences
Incorporated, Jacksonville, Florida
2000-present Member, Medical Executive Committee, Shands Jacksonville Hospital,
2000-present Member, Gradual Medical Education Committee, Shands Jacksonville Hospital,
2001-present Member, Ethics Committee, Shands Jacksonville Hospital, Jacksonville, Florida
2000-present Member, Telephone Task Force, Shands Jacksonville Hospital, Jacksonville,
Florida
1995-2002 Member, Basic and Clinical Science Course Review Committee, Continuing
Medical Education Division, American Academy of Ophthalmology

12 05/07/16
1994-2000 Member, Operating Room Committee, Richland Memorial Hospital, Columbia, South
Carolina
1994-2000 Chair, ResidentSelection Committee, DepartmentofOphthalmology, University of
South Carolina School of Medicine
1994-2000 Member, Graduate Medical Education Committee, Richland Memorial Hospital
1994-2000 Member, Education Trust Committee, University of South Carolina School of
Medicine
1994-2000 Member, Student Advisory Committee, University of South Carolina School of
Medicine
1995-2000 Member, Quality Assurance Committee, Department of Ophthalmology, University
of South Carolina School of Medicine
1995 Member, Internal Review Committee, Department of Anesthesia, Richland
Memorial Hospital
1995 Member, Internal Review Committee, Department of Emergency Medicine,
Richland Memorial Hospital
1996 Member, Internal Review Committee, Graduate Medical Education, Richland
Memorial Hospital
1997-2000 Member, Cooperative Staff of Center for Cancer Treatment and Research
1997-2000 Member, Curriculum Committee, University of South Carolina School of Medicine
PUBLIC SERVICE and CIVIC ACTIVITIES:
 Public media interview, WLTX TV, Columbia, "Floaters and their Implications" program (hostPhyllis
Dean, WIS news) July 29, 1997
 Public media interview, WSCQ TV, Columbia, "Prevention ofOcular trauma and Precautions On a July
4 weekend " program (hostMike Suber, WIS news) June 28, 1996
 Public media interview, Carolinian Magazine, Columbia, "Treatment ofAIDS patients with a new Intra
ocular device" Reporter: Karen White, June 26, 1997
 Associate Examiner to American Board ofOphthalmology, since July 1995.
 Diabetic Retinopathy and Glaucoma Screening in conjunction with South Carolina Eye Institute, South
Carolina Commission ofthe Blind and Lions Club, March 22-25, 1996
 Diabetic Retinopathy and Glaucoma Screening in conjunction with South Carolina Eye Institute, at
State Fair, August 27-29, 1996, Columbia, South Carolina
 Diabetic Retinopathy and Glaucoma Screening in conjunction with South Carolina Eye Institute, at
State Fair, September 2-6, 1995, Columbia, South Carolina
 Consultant, Ophthalmology Service,Ryan White Free AIDS Clinic, Columbia, South Carolina, July
1995-December 2000. Provide free preventive screening for IndigentPatients.

13 05/07/16
 Participant, Annual Diabetic Screening in Conjunction with Parkland Memorial Hospital Outreach
program for Indigent Population, 1992-94
 Participant, Weekly free clinic in Conjunction with Catholic Charities Church program, Jamaica, New
York, August88- June 92.
 Volunteer ResidentMember, Lions Eye Club, Queens, New York, Procured Donor eyes for corneal
transplantation, 89-92.
 Participated and performed over 1000 free cataract surgeries 1980-83, under the auspices ofthe
Rotary Club in the provinces ofHaryana and Punjab, India.
 Mentor, Minority Students, Bedford-Stuyvesantsection, Brooklyn,New York, 90-92 academic years.
 Member, Richland Memorial Hospital Curriculum developmentcommittee on role ofmedical ethics in
graduate medical education, 1995-97.
 Participant, National Eye Care projectsponsored by American Academy ofOphthalmology, 1994-
present
 Active participant, Operation sightsaver (Sponsor: Commission for the Blind) to provide NO COST
surgery with care to needy diabetics who otherwise could notafford care in an attempt to eliminate
preventable blindness in South Carolina
 Member, Board ofDirectors, AVASC Foundation, 1998-present, New York
 Volunteer Surgeon, ORBIS international flying eye hospital, 2010-present, New York
ADMINISTRATIVE EXPERIENCE:
 Chairman, Department of Ophthalmology, University of Florida College of Medicine, Jacksonville,
Florida, 11/99-present
 Residency and Fellowship Program Director, Department of Ophthalmology, University of Florida
School of Medicine, Jacksonville, Florida, 11/99-present
 Chief Administrative Officer, Department of Ophthalmology, University of Florida College of
Medicine, Jacksonville, Florida, 11/99-present
 Residency Program Director, Department ofOphthalmology at University of South Carolina School of
Medicine since 6/94 – 11/99
 Administrative Chief Resident in charge of organizing day to day residency activities at CMC
Ophthalmology program, 07/91 - 06/92
 President of House Staff body of 450 resident members at Catholic Medical Center during residency
 Extensive RRC review experience: Collected data and prepared relevant documentation for RRC visit
during chief residency year in 1992 as well as program director in 1997, 2007, and 2010. Full
accreditation was awarded on all occasions.
CLINICAL EXPERIENCE:

14 05/07/16
 Director, Vitreoretinal service, University of Florida School of Medicine, Jacksonville, Florida, 1999-
Present
 Director, Neuro-ophthalmology and Electrophysiology service, University ofFlorida School ofMedicine,
Jacksonville, Florida, 1999-Present
 Director, Vitreoretinal service, University of South Carolina School of Medicine, 1994-1999
 Director, Neuro ophthalmology and Electrophysiology service, University of South Carolina School of
Medicine, 1994-99
 Extensive experience in vitreo-retinal surgery including management of advanced PVR with modern
molecular biological agents, severe diabetic traction retinal detachments, phakoemulsification
combined with vitrectomy and severe ocular trauma. Performed over 20,000 procedures as primary
surgeon
 Specially trained in using Wide angle Vitrectomy system, Perfluorocarbon liquids and placement of
telescopic implants and therapeutic intraocular implants
 Fellowship trained in the management of Ocular tumors during Ocular oncology fellowship at MD
Anderson Cancer Center, UT Houston, Texas
 Organized Neuro-ophthalmology clinic and supervised Electrophysiology laboratory during Neuro-
ophthalmology fellowship
TEACHING EXPERIENCE:
 Grand rounds coordinator, University of Florida / Shands Jacksonville Ophthalmology Residency
Program, Jacksonville, Florida, 2000-present
 Grand rounds coordinator, Richland Memorial Hospital/University of South Carolina Ophthalmology
Residency Program, Columbia, SC 1994-Present
 Preceptor, University of South Carolina School of Medicine Students on surgery rotation and Family
practice residents of Richland Memorial Hospital 1994-2000
 Medical Student Advisor, University of South Carolina School of Medicine, 1994-2000
 Organizer: Didactic and Microscopic surgery courses to new residents instructing phacoemulsification
and basic surgical retinal skills.
 Co-director, Clinical Ophthalmology section of Physical Diagnosis, Course # D603/4, M-II, The
University of South Carolina School of Medicine, 1994 - 2000
 Co-director, Clinical Ophthalmology section of Physical Diagnosis, Course # D620, M-IV, The
University of South Carolina School of Medicine, 1994 - 2000
 Co-director, Family Practice resident Ophthalmology rotation, Richland Memorial Hospital, 1994-2000.
 Co-director, Internal Medicine resident Ophthalmology rotation, Richland Memorial Hospital, 1994-
2000.
RESEARCH EXPERIENCE:

15 05/07/16
Grants-in-Aid
1. Principal investigator of NIH Grant: “Phase III Trial-AREDS II- A Multi-Center, Randomized Trial of
Lutein, Zeaxanthin, and Omega-3 Fatty Acids in Age-Related Macular Degeneration.” Sponsor
National Eye Institute N01-EY-5-0007($126,000)
2. Co- principal investigator ofNIH Grant: “Vascular Reparative Mechanism byACE2/Ang-(1-7) in Diabetes.”
Sponsor National Eye Institute 1R01HL110170 – 01 ($253,000)
3. Principal investigator of NIH Grant “Evaluation of Vitrectomy for Diabetic Macular Edema.” Sponsor
Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14231
($164,000)
4. Principle Investigator of NIH Grant “Intravitreal Ranibizumab or Triamcinolone Acetonide in
Combination with Laser Photocoagulation for Diabetic Macular Edema”. Sponsor. Diabetic
Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($522,000)
5. Principle Investigator of NIH Grant “A pilot study in individuals with center involved diabetic macular
edema undergoing cataract surgery” Sponsor. Diabetic Retinopathy Clinical Research Network
(DRCRnet); National Eye Institute UIO EY14242 ($72,000)
6. Principle Investigator of NIH Grant “Observational study in individuals with diabetic retinopathy
without center involved diabetic macular edema undergoing cataract surgery”. Sponsor. Diabetic
Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242 ($114,000)
7. Principle Investigator of NIH Grant “An evaluation of intravitreal Ranizumab for Vitreous hemorrhage
due to Proliferative Diabetic retinopathy”. Sponsor. Diabetic Retinopathy Clinical Research Network
(DRCRnet); National Eye Institute UIO EY14242 ($172,000)
8. Principle Investigatorof NIH Grant “Intravitreal Ranibizumab or Triamcinolone Acetonide as
Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy”. Sponsor.
Diabetic Retinopathy Clinical Research Network (DRCRnet); National Eye Institute UIO EY14242
($522,000)
9. Principle Investigator of NIH Grant “Comparison of Time Domain OCT and Spectral Domain OCT
Retinal ThicknessMeasurement in Diabetic Macular Edema”. Sponsor. Diabetic Retinopathy Clinical
Research Network (DRCRnet); National Eye Institute UIO EY14242 ($522,000)
10. Principle Investigator of NIH Grant “Effects ofDiabetes education during Retinal ophthalmology visits
on diabetic control”. Sponsor. Diabetic Retinopathy Clinical Research Network (DRCRnet); National
Eye Institute UIO EY14242 ($76,000)
11. Principal investigator of NIH grant: "Ischemic Optic Neuropathy Decompression Trial, Follow up
study" 1997-2002. UIO EY09566-04 ($48,000)
12. Principal investigator of NIH grant: "Ischemic optic Neuropathy Decompression Trial" 1991-1996.
UIO EY09566-03 ($134,000)
13. Consultant for NIH grant: “Collaborative Image Annotation in Ophthalmology UIO EY09566-03. 2003-
04($98,000)

16 05/07/16
14. Principle Investigator of “A Double-Masked, Placebo-Controlled, Parallel-Group, Multi-center, Dose-
Ranging Study to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Active Sight
Threatening, Non-Infectious Anterior Uveitis”. Sponsor. Lux Biosciences, Inc.
15. Principal investigator of “A Prospective Continuation Multicenter Clinical Trial of the Implantable
Miniature Telescope (IMT) In patients with Central Vision Impairment Associated with Age-Related
Macular Degeneration.” Sponsor VISIONCARE Ophthalmic Technologies ($30,000)
16. Co-Investigator of “A Phase II/III Study of Encapsulated Human NTC-201 Cell ImplantsReleasing
Ciliary Neurotrophic Factor (CNTF) for Participants with Retinitis Pigmentosa Using Visual Acuity as
the Primary Outcome”. Sponsor. Neurotech USA, Inc. (160,000$)
17. Principal investigator of “A Phase 3 Multicenter, Randomized, Double-Masked, Controlled Study of
Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal
Neovascularization Associated with Age-Related Macular Degeneration” Sponsor: Gaenera
Corporation project no MSI-1256F-301. ($270,000)
18. Principal investigator of " A multi center randomized controlled study to evaluate the safety and
efficacy of oral gancyclovir in comparison to intravitreal Gancyclovir implant in patients with newly
diagnosed cytomegalovirus retinitis. Sponsor Syntex Project GANS. 2304 ($160,000)
19. Principal investigator of " A 12 Week, Multi-center, randomized, double-masked, three treatment
parallel group comparison of fixed combination of latanoprost and timolol vs. latanoprost vs.timolol in
glaucoma patients with optic nerve head abnormalities and visual field defects ” Sponsor Pharmacia
Project Xalcom. 912-OPT-0076-022 ($47,000)
20. Principal investigator of " A multi center randomized, double masked, controlled study to evaluate the
safety and efficacy of an intravitreal Flucinolone Acetonide (0.5 or 2 mg) Implant in Patients with
Diabetic Macular Edema. Sponsor: Bausch & Lomb Incorporated Project BL 415-007 ($400,000)
21. Principal investigator of " A multi center randomized, double masked, controlled study to evaluate the
safety and efficacy of an intravitreal Flucinolone Acetonide (0.5 or 2 mg) Implant in Patients with
Noninfectious Uveitis Affecting the Posterior Segment of the Eye. Sponsor: Bausch & Lomb
Incorporated Project BL 415-001 ($170,000)
22. Principal investigator of “A Safety and Efficacy Assessment of Chimeric Ribozyme to PCNA to
Prevent Recurrence of Proliferative Vitreoretinopathy. Sponsor: Immusol Corp. Project IM-VIT 100
($17,000)
23. Principal investigator of “Retinopathy of Prematurity screening in pre-term babies”. Sponsor.
Childrens Miracle Network. 2000-2001 ($64,000).
24. Principal investigator of “Electrophysiology Diagnostic Service for children with Retinopathy of
Prematurity in North East Florida”. Sponsor. Children’s Miracle Network. 2001-2002 ($35,000)
25. Co-investigator of “Glaucoma and Diabetic Retinopathy Screening and Awareness in South Carolina -
A Blindness Prevention Project. Sponsor: South Carolina Commission for the Blind ($15,000)
26. Co-investigator of “Oxidation in micro vascular disease”. Sponsor South Carolina Consortium for
Cardiovascular Disease and Stroke, 1997 - 98 ($17,000)
27. Co-Investigator of “Use ofperfluorocarbon liquids in management of complex retinal detachments " a
pilot study conducted at UT Southwestern Medical School. 1992- 94

17 05/07/16
28. Co-investigator of “Effects of vitreous on metalloproteinase activity in retinal pigment cells” Sponsor
South Carolina Consortium for Cardiovascular Disease and Stroke, 1997 - 98 (20,000$).
29. Co-investigator of “Anti PDGF antibodies effectively inhibit RPE induced collagen contraction in
Proliferative Vitreoretinopathy.” Sponsor. Palmetto Richland Health alliance, 1997-98 (5000$).
30. Co-investigator of “Apoptosis ofthe retinal pigment epithelial and photoreceptor cells in Age Related
Retinal Degeneration” Sponsor. Palmetto Richland Health alliance, 1998-99 (5000$).
31. Co-investigator of “Acquisition of instrumentation for the development of novel environmentally
conscious manufacturing processes employing water jet technologies” Sponsor. National Science
Foundation. 1998-99 (840,240$).
32. Co-investigator of “A Randomized double blind, Phase III comparative trial of 2 doses of ZD1839
(TRESSA) in combination with paclitaxel and carboplatin versus placebo in combination with paclitaxel
and carboplatin in chemotherapy-naïve patients with advanced (stage III or IV non-small cell lung
cancer”. Sponsor. AstraZeneca Pharmaceuticals inc. 2000-2002 (350,000$)
33. Co-investigator of “A Study to evaluate the safety and Efficacy of TAK-37 versus Placebo in Subjects
with Irritable Bowel Syndrome”. Sponsor. MDS Pharma Services. 2000-2002 (350,000$)
SCIENTIFIC REVIEWER :
 Ophthalmology
 Experimental Eye Research
 International Journal of Ocular Pharmacology
 Archives of Ophthalmology
 Current Eye Research
 Focal Points in Ophthalmology
 Investigative Ophthalmology and Visual Science
 Retina
 European Journal of Ophthalmology
 British Journal of Ophthalmology
 Journal of Medical Case Series
 BMC Ophthalmology
 Neuroscience Research
 Indian Journal of Ophthalmology
 Cutaneous and Ocular Toxicology
 Clinical Ophthalmology
 Acta Ophthalmologica
 PloS One

18 05/07/16
 Molecular Vision
 Pediatrics
MAJOR INTERESTS:
Clinical:
 Vitreo-retinal Diseases and Surgery; Uveitis and Ocular Oncology;
 Neuro-Ophthalmology
Current Research:
 Optical lens designing for vitrectomy systems
 Retinal Stem cell Isolation and transplantation
 Design of synthetic biological and chemical agents that facilitate vitreolysis
 Neuronal regeneration and retinal transplants using neural cell cultures
 Glutamate metabolism in retinal ganglion cells and evaluation of gene therapy
BIBLIOGRAPHY:
Contributions to Books & Monographs:
1. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 1997-98,
Section 2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American
Academy of Ophthalmology, San Francisco. 1997, p381-450
2. Tripathi BJ, Tripathi RC, and Chalam KV: Eye Anatomy. In ENCYCLOPEDIA OF HUMAN
BIOLOGY, ed. R. Dulbecco. 2nd edition. Academic Press, San Diego. 1997, p883-901
3. Tripathi BJ, Tripathi RC, Li J, Qian Y, Kosnosky W, and Chalam KV: Barotoxic effects on
morphology and viability of trabecular cells: A preliminary report. In ADVANCES IN OCULAR
TOXICOLOGY, ed. K. Green, H.F. Edelhauser, R.B. Hackett, D.S. Hull, D.E. Potter, and R.C.
Tripathi. Plenum Press, New York. 1997, p55-61
4. Bryan C, Li J, Tripathi BJ, Chalam KV, Pakalnis VA, Tripathi RC: Topical fluorescein application can
induce iritis and glaucoma: an unusual case report. In ADVANCES IN OCULAR TOXICOLOGY, ed.
K. Green, H.F. Edelhauser, R B. Hackett, D.S. Hull, D.E. Potter, and R.C. Tripathi. Plenum Press,
New York. 1997, p87-91
5. Weiss R, Chalam KV, Ellsworth R: Introduction to Imaging Techniques in Orbital and Ocular Tumors:
Radiology of Orbit. Editors: B Haik and M Mafee, Permagon Press 1991, p207-263
6. Tang R, Chalam KV, Musgrove K: Exercise induced oscillopsia in Arnold-Chairi Malformation:
NEURO-OPHTHALMOLOGY ENTERS NINETIES: ed: L. Smith. Dutton Press 1990, p199-207

19 05/07/16
7. Paton D, Craig J, and Chalam KV: Clinical Symposia: Management of cataracts: Vol 42 Number 4
1990 CIBA - GEIGY, p1-32
8. Tang R, Chalam KV: Ophthalmic manifestations in systemic disease: A Slide Script Manual.
American Academy of Ophthalmology, San Francisco. 1990, p1-32
9. Chalam KV: HLA - Typing in recurrent herps simplex keratitis, Thesis accepted in partial fulfillment of
Masters degree in Ophthalmology. Post Graduate Medical Institute, Chandigarh, PGI Press, India
1983, p1-132.
10. Chalam, KV., Lawler, J. Management of Diabetic Retinopathy in the New Millennium. Jacksonville
Medicine 51: 8, 2000
11. Chalam KV: Ocular Pharmacology. In: BASIC AND CLINICAL SCIENCE COURSE, 1998-99, Section
2: Fundamentals and Principles of Ophthalmology. ed. R.C. Tripathi. American Academy of
Ophthalmology, San Francisco. 1998, p381-450
17. Chalam KV: An in vitro model to study the effect of hydrostatic pressure on retinal ganglion cells and
its relevance to Glaucomatous eye disease. Thesis accepted in partial fulfillment of Doctor of
Philosophy degree. University of South Carolina, Columbia. 2004, p1-212.
18. Chalam KV, Lin S. Management of Diabetic Retinopathy in 21st Century. Jacksonville Medicine
2009
Peer Reviewed Journals:

20 05/07/16
2016
1. Grover S, Chalam K. Reply to: Normative data for macular volume with high-definition spectral-
domain optical coherence tomography (Spectralis). European Journal of Ophthalmology.
2015;25(12):546-51
2015
2. Khaja W A, Grover S, Kelmenson AT, Ferguson LR, Kumar Sambhav, Chalam KV. Comparison of
central corneal thickness: ultrasound pachymetry versus slit-lamp optical coherence tomography,
specular microscopy,and Orbscan. Clinical Ophthalmology. 2015:9 1065–1070
3. Abu-Amero K, Kondkar A A., Chalam KV. An Updated Review on the Genetics ofPrimary Open Angle
Glaucoma. International Journal of Molecular Sciences. 2015;16(12):28886-911
4. Chalam KV, Murthy RK, Priluck JC, Khetpal V, Gupta SK. Concurrent removal ofintravitreal lens
fragments after phacoemulsification with pars plana vitrectomy prevents developmentofretinal
detachment. International Journal of Ophthalmology. 2015 Feb 18;8(1):89-93
5. Sambhav K, Shakir O, Chalam KV. Bilateral isolated concurrentsuperior ophthalmic vein thrombosis
in systemic lupus erythematosus. International Medical Case Reports Journal. 2015;8:181-3
6. Chalam KV, Li W, Koushan K, Grover S, Balaiya S. Effect of distance and duration of illumination on
retinal ganglion cells exposed to varying concentrations ofbrilliant blue green. Journal of Clinical
Medical Research. 2015 ;7(7):517-24
7. Li W, Chalam KV, Grover S. Bilateral Choroidal Detachment in Waldenström Macroglobulinemia.
JAMA Ophthalmolology. 2015 Jun;133(6):715-6
8. Diabetic Retinopathy Clinical Research Network. Assessing the EffectofPersonalized Diabetes Risk
Assessments during Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. JAMA
Ophthalmology. 2015; 133(8):888-96.
9. Diabetic Retinopathy Clinical Research Network. Repeated intravitreous ranibizumab injections for
diabetic macular edema and the risk ofsustained elevation ofintraocular pressure or the need for
ocular hypotensive treatment. JAMA Ophthalmology. 2015; 133 (5):589-97.

21 05/07/16
10. Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab,or ranibizumab for diabetic
macular edema. New England Journal of Medicine. 2015; 372(13):1193-203
11. Diabetic Retinopathy Clinical Research Network. Topical nepafenec in eyes with noncentral diabetic
macular edema. Retina. 2015;35(5):944-56
12. Murthy RK, Diaz M, Chalam KV, Grover S. Normative data for macular volume with high-definition
spectral-domain optical coherence tomography (Spectralis). European Journal of Ophthalmology.
2015;25(6):546-51
13. Sambhav K, Grover S, Chalam KV. Evaluation ofportable digital fundus video camera for fluorescein
angiography. Retina. 2015 Dec 29
2014
14. Haji S, Sambhav K, Grover S, Chalam KV. Evaluation of the iPad as a low vision aid for improving
reading ability. Clinical Ophthalmology. 9:17-20, 2014
15. Ferguson LR, Grover S, Dominguez JM, Balaiya S, Chalam KV. Retinal thickness measurement
obtained with spectral domain optical coherence tomography assisted optical biopsy accurately
correlates with ex vivo histology. PLoS One. 9:10-18, 2014
16. Balaiya S, Grant MB, Priluck J, Chalam KV. Growth factors/chemokines in diabetic vitreous and
aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans. American
Journal of Endocrinology and Metabolism. 307 (8): 695-702, 2014
17. Chalam KV, Sambhav K, Grover S, Balaiya S, Murthy RK. Aqueous interleukin-6 levels are superior
to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related
macular degeneration. Journal of Ophthalmology. 502174, 2014
18. Chalam KV, Brar VS, Murthy RK. Human ciliary epithelium as a source of synthesis and secretion of
vascular endothelial growth factor in neovascular glaucoma. JAMA Ophthalmology. 132 (11): 1350-
54, 2014
19. Diabetic Retinopathy Clinical Research Network Writing Committee, Bressler SB, Edwards AR,
Chalam KV, Bressler NM, Glassman AR, Jaffe GJ, Melia M, Saggau DD, Plous OZ . Reproducibility of
spectral domain optical coherence tomography retinal thickness measurements and conversion to
equivalent time domain metrics in diabetic macular edema. JAMA Ophthalmology. 132(9):1113-22,
2014

22 05/07/16
20. Balaiya S, Koushan K, McLauchlan T, Chalam KV. Assessment of the effect of distance and duration
of illumination on retinal pigment epithelial cells exposed to varying doses of Brilliant Blue Green.
Journal of Ocular Pharmacology and Therapeutics. 30 (8): 625-33, 2014
21. Koushan K, Chalam KV. Miniaturized high-resolution wide-field contact lens for panretinal
photocoagulation. Clinical Ophthalmology. 8:703-06, 2014
22. Diabetic Retinopathy Clinical Research Network. Pilot study of individuals with diabetic macular
edema undergoing cataract surgery. JAMA Ophthalmology. 131(7):870-9, 2014
23. Diabetic Retinopathy Clinical Research Network. Evaluation of results 1 year following short-term use
of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy. JAMA
Ophthalmology. 132 (7):889-90, 2014
24. AREDS2 Research Group. Effect of long chain w-3 fatty acids and lutein+zeaxanthin supplements on
cardiovascular outcoms; results ofthe age-retlated eye disease study 2 (AREDS2) randomized clinical
trial. JAMA Ophthalmology. 132 (7):889-99, 2014
25. Murthy RK, Ravi K, Balaiya S, Brar VS, Chalam KV. Lutein protects retinal pigment epithelium from
cytotoxic oxidative stress. Cutaneous Ocular Toxicology. 33 (2): 132-7, 2014
26. Balaiya S, Chalam KV. An in vitro assay to quantify nitrosative componentofoxidative stress.Journal
of Molecular Genetics and Medicine. 8 (3): 625-33, 2014
2013
27. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Elman MJ, Bressler NM, Qin H, Beck
RW, Ferris FL, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK. Randomized clinical
trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic
retinopathy.JAMA Ophthalmology. 1 (3):283-93, 2013
28. Rusovici R, Patel CJ, Chalam KV. Bevacizumab inhibits proliferation ofchoroidal endothelia cells by
regulation of cell cycle. Clinical ophthalmology 7:321-7, 2013
29. Koushan K, Ferguson LR, Rusovici R, Chalam KV. The role of lutein in eye-related disease.
Nutrients 5(9):1823-39, 2013
30. Luo L, Uehara H, Zhang X, Das SK, Olsen T, Holt D, Simonis JM, Jackman K, Singh N, Miya TR,
Huang W, Ahmed F, Bastos-Carvalho A, Le YZ, Mamalis C, Chiodo VA, Hauswirth WW, Baffi J, Lacal
j PM, Orecchia A, Ferrara N, Gao G, Young-Hee K, Fu Y, Owen L, Albuquerque R, Baehr W, Thomas
K, Li DY, Chalam KV, Shibuya M, Grisanti S, Wilson DJ, Ambati J, Ambati BK. Photoreceptor
avascular privilege is shielded by soluble VEGF receptor-1.ELife 18(2) e00324-35, 2013
31. Balaiya S, Murthy RK, Chalam KV. Resveratrol inhibits proliferation of hypoxic choroidal vascular
endothelial cells. Molecular Vision 19.2385-92, 2013

23 05/07/16
32. Birch DG, Weleber RG, Duncan JL, Jaffe GJ, Tao W, Ciliary neurotrophic factor retinitis pigmentosa
study groups. Randomized trial ofciliary neurotrophic factor delivered by encapsulated cell intraocular
implants for retinitis pigmentosa. American Journal of Ophthalmology 156(2): 283-292, 2013
33. Murthy RK, Balaiya S, Brar V, Chalam KV. Lutein protects retinal pigment epithelium from cytotoxic
oxidative stress. Cutaneous and Ocular Toxicology 31(1): 4-9, 2013
34. Ferguson LR, Balaiya S, Grover S, Chalam KV. Retinal Thickness Normative Data in Wild-Type Mice
Using Customized Miniature SD-OCT. PLos One 8(6) e67265-34, 2013
35. Balaiya S, Murthy RK, Mylyapa RS, Grover S, Chalam KV. Differential sensitivity of choroidal
endothelial, retinal ganglion, and retinal pigment epithelial cells in vitro to proton radiation. American
Journal of Ophthalmology 156(3): 444-453, 2013
36. Murthy RK, Perez L, Priluck JC, Grover S, Chalam KV. Acute bilateral concurrent central retinal artery
occlusion in sickle cell disease after use of tadalafil (Cialis) JAMA Ophthalmology 131(11): 1471-13,
2013
37. Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG, Diabetic
Retinopathy Clinical Research Network. Exploratory analysis ofthe effect of intravitreal ranibizumab or
triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. JAMA
Ophthalmology 131(8): 1033-40, 2013
38. Bressler SB, Almukhtar T, Aiello LP, Bressler NM, Ferris FL, Greven CM. Green or yellow laser
treatment for diabetic macular edema exploratory assessment within the diabetic retinopathy clinical
research network. Retina. 33(10):870-9, 2013
39. Diabetic Retinopathy Clinical Research Network. Macular edema after cataract surgery in eyes without
pre-operative central-involved diabetic macular edema.JAMA Ophthalmology. 131(7):870-9, 2013
40. Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd;
AREDS2 Study Group.Methods and reproducibility ofgrading optimized digital color fundus
photographs in the Age-Related Eye Disease Study 2 (AREDS2 ReportNumber 2). Investigative
Ophthalmology and Visual Science. 54(7):4548-54, 2013
41. The age related eye disese study 2 (AREDS2) research Group Chew EY, Clemons TE, SanGiovanni
JP, Danis RP, Ferris FL 3rd; Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE,
Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalapally A, Friberg, T, Wong WT, Rosenfeld PJ,
Agron E, Toth CA, Bernstein PS, Sperduto RD. Secondary analysis ofthe effects oflutein/zetaxanthin
on Age related macular degeneration progression: AREDS2 reportno.3. JAMA Ophthalmology.
54(9):5989-94, 2013
42. Domalpally A, Danis RP, , Chew EY, Clemons TE, Reed S, SanGiovanni JP, Ferris FL 3rd; AREDS2
Study Group. Evaluation of optimized digital fundus reflex photographs for lens opacities in the age
related eye disease study 2. AREDS2 report7.Investigative Ophthalmology and Visual Science.
54(9):5989-94, 2013

24 05/07/16
43. Age related Eye Disease Study2 Research Group. Lutein + zeataxanthin and omega-3 fatty acids for
age related macular degeneration: the age related eye disease study 2 (AREDS2) randomized clinical
trial. Journal of American Medical Association. 309(19):2005-15, 2013
2012
44. Balaiya S, Ferguson LR, Chalam KV. Evaluation of sirtuin role in neuroprotection ofretinal ganglion
cells in hypoxia. Investigative ophthalmology and Visual Science. 53(7):4315-22. 2012
45. Chalam KV, Khetpal VJ, McLauchlan T, Murthy RK. New miniaturized contact lens for wide-angle
fundus fluorescein angiography: wide angle fluorescein angiography lens. Retina 32(3):640-2,2012
46. Chalam KV, Murthy RK, Brar V,Radhakrishnan R, Khetpal VJ, Grover S. Evaluation of a novel
noncontact, automated Focal Laser with Integrated (NAVILAS) Fluorescein angiography for Diabetic
Macular Edema. Middle East African Journal of Ophthalmology19(1):158-62, 2012
47. Glassman AR, Stockdale CR, Beck RW, Baker C, Bressler NM for Diabetic Retinopathy Clinical
Research Network. Evaluation of masking study participants to intravitreal injections in a randomized
clinical trial.Archives of Ophthalmology. 130(2):190-194. 2012
48. Chalam KV, Khetpal VJ, Patel CJ. Spectral domain optical coherence tomography documented rapid
resolution of psuedophakic cystoids macular edema with topical difluprednate.Clinical
Ophthalmology 6: 155-8, 2012
49. Balaiya S, Khetpal VJ, Chalam KV. Hypoxia initiates sirtuin1 mediated vascular endothelial growth
factor activation in choroidal endothelial cells through hypoxia inducible factor 2α. Molecular
Vision18:114-20, 2012
50. Grover S, Kelmenson AT, Chalam KV, Edward DP. Webcasts for resident education.
Ophthalmology118(1):199-200, 2012
51. Sun JK, Qin H, Aiello LP, Melia M, Beck RW, Chalam KV. (Diabetic Retinopathy Clinical Research
Network). Evaluation ofvisual acuity measurements after autorefraction vs manual refraction in eyes
with and without diabetic macular edema. Archives of Ophthalmology. 130(4):470-9. 2012
52. Chalam KV, Peck CC, Grover S, Radhakrishnan R. Lenticular meridional astigmatism secondary to
iris mesectodermal leiomyoma. Cataract and Refractive Surgery38(1):170-73, 2012
53. Balaiya S, Mylyapa RS, Hsi W, Murthy RK, Chalam KV. Evaluation of proton beam radiation
sensitivity of proliferating choroidal endothelial and retinal ganglion cell proliferation with clonogenic
assay. Cutaneous and Ocular Toxicology31(1): 4-9, 2012
54. ARED2 Research group, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Danis R. Age related
eye disease study 2 ( AREDS2) : Study Design and baseline characteristics ( AREDS2 Report
Number 1). Ophthalmology. 119(11):2282-9, 2012

25 05/07/16
55. Chalam KV, Bressler SB, Edwards AR, Berger BB, Grover S, Gupta SK, Neilsen JS. Retinal thickness
in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical
coherence tomography. Investigative Ophthalmology and Visual Science.13;53(13):8154-61, 2012
56. Chalam KV, Murthy RK,Gupta SK, Khetpal VJ. Prophylactic circumferential intraoperative laser
retinopexy decreases the risk of retinal detachment after macular hole surgery.European Journal of
Ophthalmology 18(2):255-62, 2012
57. Bressler NM, Miller KM, Beck RW, Bressler SB, Glasman AR, Kitchens JW,Melia M, Schlossmann
DK. Observational study of subclinical diabetic macular edema. Eye. 26(6):833-40, 2012
58. Chalam KV, Patel CJ, Edwards J, Murthy RK. T-cell leukemia. Ophthalmology. 119(8):1713-
1714.2012
59. Bressler SB, Qin H, Beck RW, Chalam KV, Kim JE, Melia M, Wells JA. Factors associated with
changes in visual acuity and central subfield thickness at1 year after treatment for diabetic macular
edema with ranibizumab. Archives of Ophthalmology. 1:130(9):1153-61. 2012
60. Priluck JC, Chalam KV, Grover S. Spectral-domain optical coherence tomography ofRoth spots in
multiple myeloma. Eye 26(12):1588-9. 2012
61. Ferguson LR, Balaiya S, Grover S, Chalam KV. Modified protocol for in vivo imaging of wild-type
mouse retina with customized miniature spectral domain optical coherence tomography (SD-OCT)
device. Biological Procedures Online. 14(1):9. 2012
62. Priluck JC, Grover S, Chalam K. Meridional lenticular astigmatism associated with bilateral concurrent
uveal metastases in renal cell carcinoma. Clinical Ophthalmology.;6:1839-41.2012
63. Diabetic Retinopathy Clinical Research Network, Elmana MJ, Qin H, Aiello LP, Beck RW, Bressler
NM, Ferris FL III, Glassman AR, Maturi RK, Melia M. Intravitreal ranibizumab for diabetic macular
edema and promptvs deferred laser treatment: 3-year randomized trial results.Ophthalmology.
119(7):2312-18, 2012
64. Bhavsar AR, Stockdate CR, Ferris FL III, Brucker AJ, Bressler NM, Glassman AR for Diabetic
Retinopathy Clinical Research Network. Update on risk of endophthalmitis after Intravitreal drug
injections and potential impact ofelimination oftopical antibiotics.Archives of Ophthalmology.
1:130(6):809-10. 2012
2011
65. Rusovici R, Sakhalkar M, Chalam KV. Evaluation of cytotoxicity of bevacizumab on VEGF-enriched
corneal endothelial cells. Molecular Vision17:3339-46, 2011
66. Chalam KV, Balaiya S, Mylyappa RS, Hsi W, Brar VS,Murthy RK. Evaluation of choroidal endothelial
cell proliferation after exposure to varying doses of proton beam radiation.Retina 31(1): 169-76, 2011

26 05/07/16
67. Chalam KV, Gupta SK, Brar VS, Murthy RK. Spectral domain OCT features of multiple subfoveal
retinal pigment epithelial tears after intravitreal bevacizumab. Indian Journal of Ophthalmology.
59(1): 47-8
68. Balaiya S, Grover S, Chalam KV. Freezing adversely effects measurement of vascular endothelial
growth factor levels in human aqueous samples. Clinical Ophthalmology 5: 1-5, 2011
69. Murthy RK, Grover S, Chalam KV. Temporal macular thinning on Spectral-domain Optical Coherence
Tomography in proliferative sickle cell retinopathy. Archives of Ophthalmology 129(2): 247-9, 2011
70. Chalam KV, Balaiya S, Mylyappa RS, His W, Brar VS,Murthy RK: Comparative in vitro safety analysis
of dyes for chemovitrectomy- Indocyanin Green, Brilliant Blue Green, Bromophenol Blue, and
infracyanine Green.. Retina 31(6):1128-36, 2011
71. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Gangaputra S, Almukhthar T,
Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD . Comparision of film and
digitalfundus photographs in eyes of individuals with diabetes mellitus. InvestigativeOphthalmology
& Visual Science.52(9):6168-6173, 2011
72. Balaiya S, Edwards J, Tillis T,Khetpal V, Chalam KV. Tumor necrosis factor –alpha (TNF-α) levels in
aqueous humor of primary open angle glaucoma.Clinical Ophthalmology.5: 553-6, 2011
73. Chalam KV, Khetpal V, Rusovici R, Balaiya S. A review: Role of ultraviolet radiation in age related
macular degeneration. Eye and Contact Lens.37:225-232, 2011
74. Chalam KV, Lin S, Gupta SK, Brar VS, Murthy RK, Radhakrishnan R. Evaluation of modified
retinopathy ofprematurity screening guidelines using birth weightas the sole inclusion criterion.Middle
East African Journal of Ophthalmology18(3):214-19, 2011
75. Grover S, Brar VS, Murthy RK, Chalam KV. Infrared imaging and spectral-domain optical coherence
tomography findings correlate with microperimetry in acute macular neuroretinopathy: a case report.
Journal of Medical Case Reports5:536-39, 2011
76. Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis MD, Ferris F, Glassmann AR,
Maturi RK, Stockdale CR, Topping FOR THE DIABETIC RETINOPATHY CLINICAL RESEARCH
NETWORK.,Rationale for diabetic retinopathy clinical research network treatment protocol for center
involved diabetic macular edema. Ophthalmology. 118:e5-14, 2011
77. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Elman MJ, Bressler NM, Qin H, Beck
RW, Ferris FL, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK. Expanded 2-year
follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic
macular edema.Ophthalmology. 118 (6):609-14, 2011
78. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Elman MJ, Aiello LP, Beck RW,
Bressler NM, Bressler SB, Edwards AR, Ferris FL, Friedman SM, Glassman AR, Miller KM, Scott IU,
Stockdale CR, Sun JK. Randomized trial evaluating short term effects of intravitreal ranibizumab or
triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes
also receiving panretinal photocoagulation. Retina. 31:1009-27, 2011

27 05/07/16
79. Chalam KV, Brar VS. Proteomics in practice: Potential consequences oflong term anti-VEGF therapy.
Retinal Physician6:26-9, 2011
2010
80. Sharma RK, Rogojina AT, Chalam KV.Bevacizumab therapy normalizes the pathological intraocular
environment beyond neutralizing VEGF. Molecular Vision16: 2175-84,2010
81. Sharma RK, Balaiya S, Chalam KV. Bevacizumab suppression ofestablishmentofmicrometastasis in
experimental ocular melanoma InvestigativeOphthalmology & Visual Science.51(12):6, 2010
82. Brar VS, Sharma RK, Murthy RK, Chalam KV. Bevacizumab neutralizes the protective effect of
Vascular Endothelial Growth Factor on Retinal ganglion cells. Molecular Vision 16: 2175-84,2010
83. Murthy RK, Brar VS, Chalam KV. Evaluation of ultra wide angle ‘ora-ora’ high refractive index self-
stabilizing contact lens for vitreous surgery. Retina 30(9):1551-3,2010
84. Ambatipudi, S, Goyal J, Shah GY, Pathangey A, Das T,Chalam KV. Novel dyes in intraocular surgery.
American Journal of Ophthalmology 150(3):442-3, 2010
85. Murthy RK, Storm L, Grover S, Chalam KV. In-vivo high resolution imaging of Optic Nerve Head
Drusen using Spectral- domain Optical Coherence Tomography. BMC Medical Imaging10:11, 2010
86. Murthy RK, Grover S, Chalam KV. Sequential spectral domain OCT documentation of retinal changes
after branch retinal artery occlusion. Clinical Ophthalmology 2010; 4:327-9
87. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK, Elman MJ, Aiello LP, Beck RW,
Bressler NM, Bressler SB, Edwards AR, Ferris FL, Friedman SM, Glassman AR, Miller KM, Scott IU,
Stockdale CR, Sun JK. Randomized trial evaluating ranibizumab plus prompt or deferred laser or
triamcinolone plus prompt laser for diabetic macular edema.Ophthalmology. 117 (6):1064-77, 2010
88. Murthy RK, Chalam KV. Assistant Independent OptiFlex system for contact as well as non contact
wide angle viewing in vitreo-retinal surgery. Archives of Ophthalmology 128(4):490-2, 2010
89. DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK,Writing committee, Haller JA, Qin H,
Apte RS, Beck RW, Bressler NM, Browning DJ, Danis RP, Glassman AR, Googe JM, Kollman C,
Lauer AK, Peters MA, Stockman ME. Vitrectomy outcomes in eyes with diabetic macular edema and
vitreomacular traction.Ophthalmology. 117 (6):1087-93, 2010
90. Chalam KV, MurthyRK, Gupta SK, Brar VS. Spectral-domain OCT guided photodynamic therapy for
choroidal hemangioma. Cases Journal. 2: 8778, 2010
91. Balaiya S, Murthy RK, Brar VS, Chalam KV. Evaluation of Ultraviolet light toxicity on cultured Retinal
Pigment Epithelial and Retinal Ganglion cells. Clinical Ophthalmology 4:33-9, 2010

28 05/07/16
92. Chalam KV, Gupta SK, Brar VS, Murthy RK, Grover S. Foveal structure delineated by Spectral-
domain Optical Coherence Tomography correlates with visual function after Macular Hole surgery.
European Journal of Ophthalmology 2010; 20(3):572-7
93. Chalam KV Balaiya S, Murthy RK. Accurate estimation of Vascular Endothelial Growth Factor levels
in micro samples with a low cost bead based assay. Retina2010; 30(5):815-9
94. Grover S, Murthy RK, Brar VS, Chalam KV. Comparison of retinal thickness in normal eyes using
Stratus and Spectralis Optical Coherence Tomography. InvestigativeOphthalmology & Visual
Science.2010; 51(5):2644-7
95. Kelmenson, AT, Brar VS, Chalam KV. Fundus autoflourescene and microperimetry detect Plaquenil
toxicity before changes in visual acuity.European Journal of Ophthalmology20(3):572-7, 2010
96. Chalam KV, Murthy RK. Spectral domain OCT documented resolution of pseudophakic cystoid
macular edema after intravitreal Triamcinolone. Ophthalmology and Eye diseases2010;2:1-4
2009
97. Chalam KV, Murthy RK. Spectral domain OCT features of hypotonous maculopathy after successful
retinal detachment surgery. Retinal Cases and Brief Reports
98. Chalam KV, Shah VA. Modified portable digital camera for screening of diabetic retinopathy.
Ophthalmic Research 28;42(1):60-62,2009
99. Chalam KV, Agarwal S, Brar VS, Murthy RK, Sharma RK .Evaluation of cytotoxic effects of
bevacizumab on human corneal cells. Cornea 28(3):328-33,2009
100. Browning DJ, Apte RS, Bressler SB, Chalam KV, Danis RP, Davis MD, Kollman C, Qin H, Sadda S,
Scott IU; FOR THE DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK.,Association of the
the extent of Diabetic macular edema as assessed by Optical Coherence Tomography with visual
acuity and retinal outcome variables - Retina. 23 (6):815-820, 2009
101. Grover S, Sharma R, Chalam KV. Intracameral Bevacizumab Effectively Reduces Aqueous VEGF in
Neovascular Glaucoma British Journal of Ophthalmology93(2):273-4,2009
102. Gupta S, Syed F, Murthy RK, Brar VS, Chalam KV. Sinonasal lymphoma masquerading as persistent
blepharoconjunctivitis. Orbit,28(1):34-6,2009
103. Grover S, Murthy RK, Brar VS, Chalam KV. Normative Data for Macular Thickness by High-Definition
Spectral-Domain Optical Coherence Tomography (Spectralis).American Journal of
Ophthalmology148(2): 266-71,2009

29 05/07/16
104. Sharma RK, Chalam KV,. In vitro evaluation of bevacizumab toxicity on retinal ganglion cell line, Acta
Ophthalmologica, 87(6):618-22,2009
105. Sharma RS, Chalam KV,. Multiplex immunoassay analysis of biomarkers in clinically accessible
quantities of human aqueous humor , Molecular Vision, 15:60-9 . 2009
106. Parappuam S, Chang B, Li L, Hartung R, Chalam, KV., Hunt DM., Hunt, RC.,Differential effects of
TGF Beta and Vitreous on thetransformation of Human Pigment Epithelial Cells. Investigative
Ophthalmolology and Visual Science 50(12)5965-74, 2009
107. Chalam KV, MurthyRK, AgarwalS, GuptaS, GroverS. Comparative Efficacy of Topical Tetravisc vs.
Lidocaine Gel in Cataract Surgery. BMC Ophthalmology9:7,2009
108. Brar VS, Sharma RK, Murthy RK, Chalam KV. Evaluation of differential toxicity of varying doses of
Bevacizumab on retinal ganglion cells, retinal pigment epithelial cells and vascular endothelial growth
factor enriched choroidal endothelial cells. Journal of Ocular Pharmacology and
Therapeutics.25(6):507-11, 2009
109. Balaiya S, Murthy RK, Brar VS, Chalam KV. Effects of Indocyanine Green on Cultured Retinal
Ganglion Cells In-Vitro. BMC research notes 2: 236, 2009
110. Brar VS, Murthy RK, Chalam KV.Functional microperimetry and SD-OCT confirm consecutive retinal
atrophy from optic nerve pit.Clinical Ophthalmology.3:625-8, 2009
111. Shah VA, Chalam KV. Values for Macular Perimetry Using MP-1 microperimeter in Normal Subjects.
Ophthalmic Research. 41(1):9-13, 2009
2008
112. Chalam KV, Gupta SK, Brar V. Inverse Argyll Robertson Pupil in Burkitt’s lymphoma. Clinical
113. Chalam KV, Brar VS, Agarwal S.Direct Image Creating Aspheric Lens for Indirect Ophthalmoscopy.
Ophthalmic Research.2007.40(2):94-7, 2008
114. Chalam KV, Gaurav Y Shah, Swati Agarwal, Shailesh Gupta. Illuminated Curved 25 Gauge Levels
Vitrectomy Probe for removal of Subsclerotomy Vitreous in Vitreoretinal Surgery. Indian Journal of
Ophthalmology. 56(4):331-4, 2008.
115. Gupta S, Brar VS, Murthy RK, Chalam KV., Aplastic anemia induced disc edema and visual loss in
pregnancy: a case report.Cases Journal. 2008;1(1):322- 4
116. Chalam KV, Shailesh Gupta, Sandeep Grover, Swati Agarwal. Intracameral Avastin Dramatically
Resolves Iris Neovascularization and Reverses Neovascular Glaucoma. European Journal of

30 05/07/16
117. Chalam KV, Tina Tillis, Syed F, Agarwal S. Acute Bilateral Simultaneous Angle Closure Glaucoma
after Topiramate Administration: a case report. J Med Case Reports 8;2:1, 2008
118. Chalam KV, Sharma Rk, Murthy RK. Limitations and difficulties in assessing nerve growth factor
levels in aqueous humor samples from human eyes. BMC Research Reports 1:22,2008
119. Chalam KV, RK Murthy, Brar VS. Spectral domain Optical Coherence Tomography documented
resolution ofrecalcitrant macular edema after intravitreal Bevacizumab in Branch Retinal Vein
Occlusion. European Journal of Ophthalmology. 2008 18 (5): 831-3
120. Chalam KV, Murthy RK. Reusable sutureless silicone ring for housing contract lens during
vitreoretinal surgery. Retina28 (10):1550-1, 2008
121. Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL,
Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H; Diabetic Retinopathy Clinical Research
Network: Diabetic retinopathy research Network team: Optical Coherence Tomography measurements
and analysis methods in optical coherence tomography studies ofdiabetic macular edema. (University
of Florida, Chalam, K.V, P.l.) Ophthalmology. 115 (8):1366-71, 2008
122. Callanan DG, Jaffe GJ,, Martin DF, Pearson PA, Comstock TL, and Fluocinolone Acetonide Uveitis
Study Group: Treatment ofPosterior Uveitis with a Fluocinolone Acetonide Implant (Retisert) : Three
year clinical results (University of Florida, Chalam, K.V, P.l.). Archives of Ophthalmology 126(9):
1191-201, 2008.
2007
123. Chalam KV, Gupta SK, Swati Agarwal. Rituximab Effectively Reverses Papilledema Associated with
Cerebral Venous Sinus Thrombosis in Anti Phospholipid Antibody Syndrome. European journal of
Ophthalmology. 5:867-70, 2007
124. Chalam KV, Amit Chokshi, Swati Agarwal, Deepak Edward. Complications of Alphacortm
Keratoprosthesis- A Clinicopathologic Report. Cornea26(10):1258-60,2007
125. Chalam KV, Swati Agarwal, Gupta SK. Light Weight Autoclavable Wide-Angle Contact Lens for
Vitreous Surgery. Ophthalmic Surg Lasers Imaging.38(6):523-4,2007
126. Chalam KV,Swati Agarwal, Gupta SK Recovery of Retinal sensitivity after branch retinal artery
occlusion.Ophthalmic Surg Lasers Imaging.38(4):328-9, 2007
127. Chalam KV, Vinay Shah. 20G Illuminated Curved Vitrectomy Probe for Vitreoretinal Surgery
Ophthalmic Surg Lasers Imaging. 2007. 38(4):525-6, 2007
128. Scherer RW, Feldon SE, Levin L, Langenberg P, Katz J, Keyl PM, Wilson D,. Kelman SE, Dickersin K,
and Ischemic Optic Neuropathy Decompression Trial Research Group: Visual Fields at Follow-up in
the Ischemic Optic Neuropathy Decompression Trial(South Carolina Eye Institute, Chalam, K.V, P.l.):
Evaluation of Change in Pattern Defect and Severity Over Time Ophthalmology. 125:1161-1167,
2007

31 05/07/16
129. William M. Schiff, MD; John C. Hwang, MD; Michael D. Ober, MD; Jeffrey L. Olson, MD; Elona
Dhrami-Gavazi, MD; Gaetano R. Barile, MD; Stanley Chang, MD; Naresh Mandava, MD: Safety and
Efficacy Assessment of Chimeric Ribozyme to Proliferating Cell Nuclear Antigen to Prevent
Recurrence of Proliferative Vitreoretinopathy (University of Florida, Chalam, K.V, P.l.) Archives of
Ophthalmology. 125:1161-1167, 2007
130. Hartung R, Ganti R, Parappuam S, Chalam, KV., Hunt DM., Hunt, RC.,Vitreous induces heme
oxygenase-1 expression mediated by transforming growth factor-β and reactive oxygen species
generation in human retinal pigment epithelial cells. Molecular Vision. 13:66-78, 2007
131. Sharma RS, Chalam KV,. Letter. Scratch Technique and evaluation of cytotoxicity of Bevacizumab.
British Journal of Ophthalmology. 2007
132. Sharma RS, Chalam KV,. Letter. Experimental conditions and RPE cytotoxicity. Investigative
Ophthalmology and Visual Science.2007
133. Sharma RS, Chalam KV,. Letter. In appropriate choice of animal age for investigating retinal
progenitor cells. Investigative Ophthalmology and Visual Science.2007
2006
134. Chalam KV, Shah V. Resolution ofmacular scotoma after radial optic neurotomy in central retinal vein
occlusion. Ophthalmic Surgery, Lasers and Imaging. 37(1):72-5,2006
135. Chalam KV, Gupta SK, Shah GY, Agarwal S. Successful management of melanocytoma associated
CNV with Photodynamic Therapy. European Journal of Ophthalmology. 16(5): 776-8
136. Chalam KV, Shah GY, Rappaport k, Shah VA. Choroidal neovascularization associated with ocular
melanocytoma of the optic disc. Retina26(6):703-4,2006
137. Chalam KV, Shah GY, Shah VA. Evaluation of web based Annotation of ophthalmic Images for multi-
center clinical trials. Indian Joural of Ophthalmology 54(2):126-9, 2006
138. Chalam, KV, IONDT Research Group: Development and validation of a computerized expert system
for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression (South
Carolina Eye Institute, Chalam, K.V, P.l.). BMC Ophthalmology 6: 34-42, 2006.
139. Glenn J. Jaffe MD, Daniel Martin MD, David Callanan MD, P. Andrew Pearson MD, Brian Levy OD,
MS, Timothy Comstock OD, MS and Fluocinolone Acetonide Uveitis Study Group: Fluocinolone
Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis ,Thirty-Four–Week Results of a
Multicenter Randomized Clinical Study (University of Florida, Chalam, K.V, P.l.). Ophthalmology
113: 1020-27, 2006.
140. Shah VA, Shah GY, Chalam KV, Letter Endophthalmitis following 25-guage vitrectomy Eye.
20(6):735-36, 2006
141. Shah V. Chalam KV. Letter regarding correlation of retinal sensitivity measured with fundus related
microperimetry to visual acuity and retinal thickness in eyes with diabetic macular oedema. Eye. 20
(11) 1307-08, 2006

32 05/07/16
2005
142. Chalam KV, Shah GY. Letter. Vitrectomy with or without arteriovenous adventitial sheathotomy for
macular edema associated with branch retinal vein occlusion. American Journal of
Ophthalmology139 (6):1146, 2005
143. Chalam KV, Shah VA. Two piece Dual Purpose Comprehensive Contact Lens system for Vitreous
surgery. Ophthalmic Research 37(4):175-178, 2005
144. Chalam KV, Gupta SK, Agarwal S, Shah V. Sutureless Limited Vitrectomy for Positive Vitreous
Pressure in Cataract Surgery. Ophthalmic Surgery, Lasers and Imaging 36:518- 522, 2005
145. Chalam KV, Shah VA. Severe Bilateral Posterior Ischemic Optic Neuropathy as a Complication of
Spinal Surgery. Eye 19(3):367-8, 2005
146. Shah VA,Chalam KV. Intraocular Central Retinal Vein. Ophthalmic surgery, lasers and Imaging
36(2):174-6, 2005)
2004
147. Chalam KV, Shah VA. Successful Management of Cataract Surgery Associated
Vitreous Loss with Sutureless Small Gauge Pars Plana Vitrectomy. American Journal of
Ophthalmology 138(1): 79-84, 2004
148. Chalam KV, Shah VA, Tripathi RC. A curved vitrectomy probe. Ophthalmic surgery, lasers and
Imaging 35(3):259-260, 2004
149. Chalam KV, Shah VA. Macular Infarction a presentation of Sickle Cell Crisis. Eye 18(12): 1277-8,
2004
150. Chalam KV, Shah VA. Self-Illuminated Contact Lens for Peripheral Vitreous Surgery. Ophthalmic
Surgery Laser and Imaging35(1): 76-77, 2004
151. Chalam KV, Pakalnis VA, Shah VA, Tripathi RC, Tripathi BJ, Yee D. Cataract in Kniest Dysplasia:
Clinicopathological Correlation. Archives of Ophthalmology 122(6): 913-915, 2004
152. Chalam KV, Shah VA. A newly designed guarded radial neurotomy knife. Retina24(5) 817-8, 2004
153. Chalam KV,Shah VA. Suction Assisted Self-Retaining two piece non-cased wide-angle Contact Lens
for Vitrectomy. Ophthalmic surgery, lasers and Imaging 35(4):345-6 2004
154. Chalam KV, Shah VA. Optics of wide-angle panoramic viewing system assisted vitreous surgery.
Survey of Ophthalmology 49(4): 437-445, 2004
155. Chalam KV, Shah VA. Self-Retaining Contact Lens system for Vitreous Surgery. Indian Journal of
Ophthalmology. 52(1): 67-71, 2004
156. Chalam KV, Shah VA. Small Contact surface minified wide angle contact lens for pediatric vitreous
surgery. Journal ofPediatric Ophthalmology & Strabismus 41(2): 109-111, 2004

33 05/07/16
157. Chalam KV, Vinjamaram S, Shah VA. Slitlamp Biomicroscopy adapter for simultaneous
photodocumentation during clinical assessment. Journal of Cataract and Refractive Surgery.
34(8):1808-9, 2004
158. Chalam, KV, Shah VA. Liquid crystal display microperimetry in eyes with macular pathology.Indian
Journal of Ophthalmology52(4): 293-6, 2004
159. Chalam KV, Shah VA. Author’s reply. Successful Management of Cataract Surgery Associated
Vitreous Loss with Sutureless Small Gauge Pars Plana Vitrectomy. American Journal of
Ophthalmology 138(6): 1091, 2004
160. Chalam KV. Author’s reply. Small Gauge Sutureless pars plana Vitrectomy to manage Vitreous Loss
during Phakoemulsiification. Journal of Cataract and Refractive Surgery30(11):2253, 2004
161. Shah VA, Gupta, SK, Shah VK, Vinjamaram S, Chalam KV: TTO utility scores measure quality of life
in patients with visual morbidity due to diabetic retinopathy or ARMD Ophthalmic Epidemiology.
11(1):43-51, 2004
162. Shah VA,Chalam KV. Congenital Retinal Macrovessel Causes reduced Retinal sensitivity at the
Macula. European Journal of Ophthalmology 14(4):341-44, 2004
163. Shah VA, Chalam KV.Autoclavable two-piece non cased wide-angle contact lens system for
vitrectomy. Ophthalmic Research36(2):94-97, 2004
164. Shah VA, Chalam KV. Liquid Crystal Display Microperimetry in Idiopathic Subretinal Fibrosis.
Ophthalmic Surgery and Lasers 35(4): 321-4, 2004
165. Shah VA, Chalam KV. Autoclavable Wide-Angle Contact Lens for Vitreous Surgery. American
Journal of Ophthalmology 137(2): 359-60, 2004
2003
166. Chalam KV, Patel CC, Shah VA. Newly Designed Self-Retaining Contact Lens for Vitreous Surgery.
American Journal of Ophthalmology 135(4): 544-546, 2003
167. Chalam, K.V, Gupta SK, Vinjamaram S, Shah VA. Congenital Anomalous Retinal Artery associated
with a Leaking Macroaneurysm- A Case Report. Archives of Ophthalmology. 121: 409-410, 2003
168. Chalam KV, Roche Gancyclovir Study Group. Endophthalmitis after gancyclovir implant in patients
with AIDS and cytomegalovirus treated retinitis. (South Carolina Eye Institute, Chalam, K.V, P.l.)
American Journal of Ophthalmology 136(4): 649-654, 2003
169. Chalam KV, Shah VA, Gupta SK, Tripathi RC. Evaluation of Lens and Peripheral Retinal
Relationships with the Use of Newly Designed Curved Endolaser and Vitrectomy Probes. Retina23
(6):815-820, 2003
170. Chalam KV, Gupta SK, Vinjamaram S, Shah VA. Small Gauge Sutureless pars plana Vitrectomy to
manage Vitreous Loss during Phakoemulsiification. Journal of Cataract and Refractive
Surgery29:1482-1486, 2003
171. Chalam KV, Malkani S, Shah VA. Intravitreal Dexamethasone Effectively Reduces Postoperative
Inflammation After Vitreoretinal Surgery. Ophthalmic Surgery and Lasers. 34 (3): 188-192; 2003

34 05/07/16
172. Chalam, KV, IONDT Research Group: Comparison of Information Obtained by Operative Note
Abstraction to That Recorded on a Standardized Data Collection Form. (South Carolina Eye Institute,
Chalam, K.V, P.l.) Surgery. 133: 324-330.2003.
173. Chalam, KV, IONDT Research Group: Surgical Quality Assurance in the Ischemic Optic Neuropathy
Decompression Trial. (South Carolina Eye Institute, Chalam, K.V, P.l.) Controlled Clinical Trials.
24(3):294-305.2003
174. Shah VA, Chalam KV. Self-Stabilizing Wide-Angle ContactLens for Vitreous Surgery. Retina23:667-
669, 2003
175. Shah VA, Chalam KV. Newly Designed Self-Retaining Prism Contact Lens for Vitreous Surgery.
Retina 23:721-722, 2003
176. Shah VA, Chalam KV.Suction Assisted one piece Self-Retaining Wide-angle Contact Lens for
Vitrectomy. Ophthalmic Research 35(3):170-172, 2003
177. Shah VA, Gupta SK, Chalam KV. Management of vitreous loss during cataract surgery under topical
anesthesis with transconjunctival vitrectomy system. European Journal of Ophthalmology 13 (8):
693-6, 2003
2002
178. Chalam KV, Gupta SK, Tripathi, R.C., Gandham, S. Parsplana Modified Baerveldt Implant versus
ND:Yag Cyclophotocoagulation in the Management of Neovascular Glaucoma. Ophthalmic Surgery
and Lasers. 33: 383-393, 2002
179. Chalam, K.V, Panthagani, P., Tripathi, R.C.: Metastatic Aspergillus Terreus Endophthalmitis
secondary to Bone Infection in Immunocompromised Host. Annals of Ophthalmology. 34(2): 153-
156, 2002
180. Chalam, KV, IONDT Research Group: The Fellow Eye in NAION: Report from the Ischemic Optic
Neuropathy Decompression Trial Follow-up Study. (South Carolina Eye Institute, Chalam, K.V, P.l.)
American Journal of Ophthalmology. 134: 317-328, 2002
2001
181. Das, T., Sharma, S., Singh, J., Rao, D.V., Chalam, KV.: Evaluation of Glutaraldehyde and Providone
Iodine for sterilization of Wide Field Contact Vitrectomy Lenses. Ophthalmic Surgery and Lasers.
32(4): 300-304, 2001
2000
182. Chalam, KV, Li, J., Tripathi, R.C.: Occurrence of Atypical Acute Bilateral Multifocal Choroidal
Neovascularization in Membranoproliferative Glomerulonephritis Type II. Annals of Ophthalmology
32(4):320-24, 2000

35 05/07/16
183. Chalam, KV, IONDT Research Group: The ischemic optic neuropathy decompression trial (IONDT):
Twenty Four month update. (South Carolina Eye Institute, Chalam, K.V, P.l.) Archives of
Ophthalmology. 118: 793-798, 2000
184. Malkani, S, Chalam, K.V., Tripathi, R.C. Funduscopic Changes in Ophthalmomyasis Interna, Digital
Journal of Ophthalmology. 6(1):2000 [http://www.djo.Harvard.edu/GR/Malkani/Malkani0600.htm]
1999
185. Chalam, KV, Roche Gancyclovir Study Group. Oral gancyclovir in patients with cytomegalovirus
treated with a gancyclovir implant: A randomized clinical trial. (South Carolina Eye Institute, Chalam,
K.V, P.l.) New England Journal of Medicine. 340: 1063-1070, 1999
186. Tripathi, RC, Parapuram SK, Tripathi, BJ, Zhong Y, Chalam KV.Corticosteroids and Glaucoma Risk.
Drugs and Aging 15(6):439-50,1999
187. Tsao K, Chalam, K.V., Pakalnis V.A, Tripathi, R.C. Occupational history is clue to unilateral Photic
retinopathy, Journal of Cutaneous and Ocular toxicology. 18(1): 57-63, 1999
1998
188. Chalam, KV, IONDT Research Group: The ischemic optic neuropathy decompression trial (IONDT):
Design and Methods. (South Carolina Eye Institute, Chalam, K.V, P.l.) Controlled Clinical Trials. 19:
276-298.1998
189. Tripathi, RC., Li, J., Tripathi, BJ., and Chalam, KV., Adamis, AP. Increased level of vascular
endothelial growth factor in aqueous humor of patients with neovascular glaucoma.
Ophthalmology.105:232-237,1998
1997
190. Chalam, K.V. and Tripathi, R.C. Recurrent choroidal neovascular membrane from Toxoplasmic
chorioretinal scar. Annals of Ophthalmology. 29: 306-308,1997
191. Chalam, KV, IONDT Research Group: Participation in the Ischemic Optic Neuropathy Decompression
trial: Sex, race, and age. (South Carolina Eye Institute, Chalam, K.V, P.l.) Ophthalmic
Epidemiology. 4:157-173.1997
192. Ambati J, Chalam KV, Chawla D, D'Angio CT, Guilet, EG, Rose SJ, Vanderlinde RE, Ambati BK.
Elevated GABA, glutamate, and vascular endothelial factor levels in the vitreous of patients with
proliferative diabetic retinopathy. Archives of Ophthalmology. 115: 1161-66. 1997
1996

36 05/07/16
193. Chalam, KV, IONDT Research Group: Characteristics of patients with nonarteritic ischemic
neuropathy eligible for the ischemic optic neuropathy decompression trial. (South Carolina Eye
Institute, Chalam, K.V, P.l.) Archives of Ophthalmology. 114: 1366-1374.1996
194. Tripathi, RC, Li J, Chalam KV, and Tripathi BJ. Expression of growth factor mRNAs by human
Tenon's capsule fibroblasts. Experimental Eye Research. 63: 339-346, 1996.
195. Li J, Tripathi BJ, Chalam KV, Tripathi RC. Transforming growth factor beta 1 and 2 positively regulate
TGF-1 beta mRNA expression in trabecular cells. Investigative Ophthalmolology and Visual
Science. 37: 2778-2782, 1996
1995
196. Chalam, KV, IONDT Research Group: Optic nerve decompression surgery for Nonarteritic Anterior
Ischemic optic neuropathy (NAION) is not effective and may be harmful. (South Carolina Eye Institute,
Chalam, K.V, P.l.). Journal of American Medical Association 273: 625-632 .1995.
1985
197. Dhir S.P, Munjal VP, Chalam KV, Jain IS. : A retrospective study of lacrimal gland tumors, Indian
Journal of Ophthalmology, 33(1): 47-49, 1985.
Papers Submitted to Peer Reviewed Journals:
198. Chalam KV, Shah VA. Flexcell Pressure Chamber: An In vitro system to study the effect of pressure
on growth and morphology of retinal ganglion cells. Submitted to the Ophthalmic Research
199. Chalam, K.V, Malkani, S, Tripathi, R.C.: Intravitreal Triamcinolone effectively reduces postoperative
inflammation after vitreoretinal surgery.Submitted to Retina
Peer Reviewed Abstract Publications:
1. Chalam KV, Sandeep Grover, Kumar Sambhav.Deep capillary macular perfusion index obtained with
SSADA-assisted OCT-angiography strongly correlates with degree ofnon-proliferative diabetic
retinopathy. American Academy of Ophthalmology, Las Vegas, 2015. P0475

37 05/07/16
2. S. Grover, K. Sambhav, O. Shakir, Chalam KV.. Decrease in Choroidal Thickness in Patients with
Retinitis Pigmentosa Out of Proportion to the Retinal Thickness by SweptSource OCT. American
Academy of Ophthalmology, Las Vegas, 2015. P0475
3. K Sambhav, Sandeep Grover, Chalam KV. Choroid Thickness Measured With SweptSource OCT
Strongly Correlates With Degree ofSickle Cell Disease.. American Academy of Ophthalmology,
Las Vegas, 2015. P0475
4. K.V. Chalam, MD, PhD, S. Gupta, MD. Intraviteral VEGF levels in proliferative vascular retinopathies
strongly correlate with the extent ofcapillary nonperfusion noted on wide angle angiography.
American Academy of Ophthalmology, Las Vegas, 2015. P0475
5. K Sambhav, S Grover, Chalam KV. Three Dimensional SweptSource OCT Accurately Measures
Optic Disc Volume in Primary Open Angle Glaucoma and Correlates with Severity ofVisual Field Loss
Association for Research in Vision and Ophthalmology, Denver, Colorado. 2015: 1034/B0172
6. S. Grover, K. Sambhav, O. Shakir, Chalam KV.. Decrease in Choroidal Thickness in Patients with
Retinitis Pigmentosa Out of Proportion to the Retinal Thickness by SweptSource OCT. Association
for Research in Vision and Ophthalmology, Denver, Colorado. 2015: 1034/B0172
7. Sankarathi Balaiya, Maria B. Grant, Chalam KV. Characterization of Vitreous proteome from Human
Proliferative Diabetic Retinopathy Subjects. Association for Research in Vision and
Ophthalmology, Denver, Colorado. 2015: 1034/B0172
8. Chalam KV,Sankarathi Balaiya, William B. Cook. Evaluation of the effectof varying concentration and
osmolality characteristics ofBrilliant Blue Green on Retinal PigmentEpithelial cells exposed to surgical
endoilluminator used in vitreous surgery. Association for Research in Vision and Ophthalmology,
Denver, Colorado. 2015: 1034/B0172
9. Chalam KV, K Sambhav. Choroid Thickness Measured With SweptSource Optical Coherance
Tomography in Posterior Staphyloma Strongly Correlates With Axial Length and visual acuity ofEye
Proceedings of 33nd Annual Meeting of American Society of Retina Specialists, Vienna, 2015.
p.328
10. Chalam KV, K Sambhav. SSADA assisted Angio- OCT confirms attenuation ofdeep capillary macular
vascular flow index in non proliferative diabetic retinopathy Proceedings of 33nd Annual Meeting of
American Society of Retina Specialists, Vienna, 2015. p.328
11. Wenhua Li, Sankarathi Balaiya, Maria B Grant, Chalam, KV. Aqueous Growth Factors in Proliferative
Diabetic Retinopathy Inhibit Migration of Endothelial Progenitor Cells (CD34+). Association for
Research in Vision and Ophthalmology, Orlando, Florida. 2014: 1034/B0172
12. Chalam, KV, Sankarathi Balaiya, William Scott, Lee R. Ferguson. Spontaneously Differentiated
Human Embryonic Stem Cell derived Retinal PigmentEpithelium Cells express RPE-65 and ZO-1
proteins. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014:
1362/A0118

38 05/07/16
13. Lee R. Ferguson, Chalam, KV. Fluorescence Microscopy Identification ofRetinal PigmentEpithelium-
65 and Zonular Occludens-1 Expression in Spontaneously Differentiated Human Embryonic Stem Cell
derived Retinal PigmentEpithelium Cells. Association for Research in Vision and Ophthalmology,
Orlando, Florida. 2014. 1849/A0405
14. Keyvan Koushan, Raluca Rusovici and Chalam, KV. Proliferating Retinal Vascular Endothelial Cells
are More Sensitive to Bevacizumab than Choroidal Vascular Endothelial Cells. Association for
Research in Vision and Ophthalmology, Orlando, Florida. 2014. 1944/B0209
15. Sankarathi Balaiya, Maria Grant and Chalam KV. Growth Factors/Cytokines PresentIn Diabetic
Vitreous Inhibit CD34+ Bone Marrow Derived Stem Cell Function. Association for Research in
Vision and Ophthalmology, Orlando, Florida. 2014. 1354/A0072
16. Sandeep Grover, Omar Shakir, Chad Hummel. AssessmentofMacular Thickness and Volume by
Spectraldomain Optical Coherence Tomography in Patients With Retinitis Pigmentosa. Association
for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 1406/A0263
17. Chad Kaplan, Chalam KV, Sandeep Grover. Intraocular Pressure Reduction After Tarsal Strip
Procedure. Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014.
151/A0211
18. Ashley Cowart, Lee R. Ferguson, Sankarathi Balaiya, Ghulam Hamdani, Sandeep Grover, Chalam
KV. In Vivo Optical Biopsy Derived Retinal Thickness Accurately Correlate with In Vitro Histology
Measurementin Wild-Type Mice. Association for Research in Vision and Ophthalmology,
Orlando, Florida. 2014. 2084/D0059
19. Omar Shakir, S. Grover. Spectral Domain Optical Coherence Tomography in Lipemia Retinalis.
Association for Research in Vision and Ophthalmology, Orlando, Florida. 2014. 5880/C0066
20. Chad Hummel, Sandeep Grover. Spectral Domain Optical Coherence Tomography and Fundus
Autofluorescence in Patients with Rubella Retinopathy. Association for Research in Vision and
Ophthalmology, Orlando, Florida. 2014. 3385/C0078
21. Wassia Khaja, Chalam KV, Sandeep Grover. Normative data for intraocular pressure and central
corneal thickness in preterm infants. Association for Research in Vision and Ophthalmology,
Orlando, Florida. 2014. 5913/C0099
22. Ravi Keshavamurthy, Sandeep Grover, Chalam KV. Correlation between foveal ischemia and
spectral-domain optical coherence tomography findings in retinal vein occlusion. Association for
Research in Vision and Ophthalmology, Orlando, Florida. 2014. 3892/C0194
23. Shamim A. Haji, Sandeep Grover, Balaiya Sankarathi, Chalam KV. Aqueous VEGF levels in Retinal
Vascular Occlusion (RVO) before and after Intravitreal injection of Bevacizumab Correlate with Visual
Acuity and Macular Thickness. Association for Research in Vision and Ophthalmology, Orlando,
Florida. 2014. 3917/C0219

39 05/07/16
24. Kevin Cronin, Sandeep Grover. Spectral-Domain Optical Coherence Tomography (Spectralis) and
Fundus Autofluorescence Findings in Foveal Hypoplasia. Association for Research in Vision and
Ophthalmology, Orlando, Florida. 2014. 5935/C0121
25. Sankarathi Balaiya , William B. Cook, K.V. Chalam. Effect ofSolventand Xenon light on Retinal
PigmentEpithelial toxicity. Proceedings of 32nd Annual Meeting of American Society of Retina
Specialists, San Diego, 2014. p.328
26. K V Chalam, Wenhua Li, Sandeep Grover. Evaluation ofsecond generation, portable, non-mydriatic,
digital fundus camera (Pictor Plus) for teleretinal screening ofretinal disorders. Proceedings of 32nd
Annual Meeting of American Society of Retina Specialists, San Diego, 2014. p.329
27. K V Chalam, Wenhua Li, Kumar Sambhav, Sandeep Grover. Sweptsource optical coherance
tomography is superior to SD-OCT in estimation of choroidal thickness in humans. Proceedings of
32nd Annual Meeting of American Society of Retina Specialists, San Diego, 2014.
28. Kumar Sambhav, Keyvan Koushan, Sandeep Grover, K. V. Chalam. Disposable inexpensive single
use Light-Weight High Resolution Wide Field ContactLens for Vitreo-retinal Surgery. Proceedings of
32nd Annual Meeting of American Society of Retina Specialists, San Diego, 2014. p.335
29. Sandeep Grover, Shamim A. Haji, Wassia Khaja, K.V. Chalam. Merrill Stass-Isern. Measurementof
Corneal Thickness and IOP in Preterm Babies. American Academy of Ophthalmology, Chicago,
2014. P0475
30. K V Chalam, Shailesh K Gupta, Kumar Sambhav, Sandeep Grover. Three dimensional SweptSource
OCT Accurately Measures Optic Disc Volume In Primary Open Angle Glaucoma. American Academy
of Ophthalmology, Chicago, 2014. P0380
31. K V Chalam, Kumar Sambhav, Sandeep Grover. Modified Portable Digital Camera (Pictor Plus) is as
Effective As Traditional Nonmydriatic Fundus Camera For Teleretinal Screening ofDiabetic
Retinopathy. American Academy of Ophthalmology, Chicago, 2014. P0370
32. Shailesh K Gupta, K V Chalam. Intravitreal VEGF Levels in Proliferative Sickle Cell Retinopathy
Strongly Correlates With the Extent ofCapillary Nonperfusion Noted on Wide Angle Angiography.
American Academy of Ophthalmology, Chicago, 2014. P0558
33. K V Chalam, Kumar Sambhav, Sandeep Grover. SweptSource OCTis Superior to Spectralis in
Accuracy as Well as Reproducibility ofChoroid Thickness and Volume Measurements. American
Academy of Ophthalmology, Chicago, 2014. P0571
34. A Cowart, S Balaiya, G Hamdani, S Grover, KV Chalam. In vitro optical biopsy derived retinal
thickness accurately correlate with in vitro histology measurement in wild type mice. Association for
Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223
35. S Haji S, Balaiya, S Grover, KV Chalam. Aqueous VEGF levels in retinal vascular occlusion before
and after intravitreal injection of bevacizumab correlate with visual acuity and macular thickness.
Association for Research in Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223

40 05/07/16
36. K.Koushan, R Rusovici, K.V. Chalam. Proliferating retinal vascular endothelial cells are more sensitive
to bevacizumab than choroidal vascular endothelial cells. Association for Research in Vision and
Ophthalmology, Orlando, Florida. 2013:274/ D223
37. KV Chalam, S Balaiya, Scott W,. Spontaneously differentiated human embryonic stem cell derived
retinal pigment epithelium cells express RPE-65 and ZO-1 proteins. Association for Research in
Vision and Ophthalmology, Orlando, Florida. 2013:274/ D223
38. LR Ferguson, KV Chalam. Fluorescence microscopy identification of retinal pigment epithelium -65
and Zonualar occludence -1 expression in spontaneously differentiated human embryonic stem cell
derived retinal pigment epithelium cells. Association for Research in Vision and Ophthalmology,
Orlando, Florida. 2013:274/ D223
39. R Keshavamurthy, S Grover, KV Chalam. Correlation between foveal ischemia and spectral domain
optical coherence tomography findings in retinal vein occlusion. Association for Research in Vision
and Ophthalmology, Orlando, Florida. 2013:274/ D223
40. W Li, S Balaiya, Grant MB, KV Chalam. Aqueous growth factors in proliferative diabetic retinopathy
inhibit migration of endothelial progenitor cells (CD 34+). Association for Research in Vision and
Ophthalmology, Orlando, Florida. 2013:274/ D223
41. S Balaiya, Grant MB, KV Chalam. Growth factors/cytokines presentin diabetic vitreous inhibit CD 34+
bone marrow derived Stem cell function. Association for Research in Vision and Ophthalmology,
Orlando, Florida. 2013:274/ D223
42. K.V. Chalam, MD, PhD, S. Gupta, MD. Intraviteral VEGF levels in proliferative vascular retinopathies
strongly correlate with the extent of capillary nonperfusion noted on wide angle angiography.
American Academy of Ophthalmology, New orleans, p.232, 2013
43. S. Gupta, MD, K.V. Chalam, MD, PhD, S. Grover, MD , K.Koushan, MD,. Modified retinopathy of
prematurity screeing guidelines using birth weight as the only criterion. American Academy of
Ophthalmology, New orleans, p.232, 2013
44. S. Gupta, MD, R Keshavamurthy, MD, J Priluck, MD, K.V. Chalam, MD, PhD, Change in macular
volume (Spectral domain OCT) is superior to macular thickness in predicting functional recovery in
diabetic macular edema after anti VEGF therapy. American Academy of Ophthalmology, New
orleans, p.232, 2013
45. K.V. Chalam, MD, PhD, S. Gupta, MD, S. Grover,. Spectalis obtained SD-OCT is superior to Cirrus in
accuracy as well as reproducibility of retinal thickness and volume measurements. American
Academy of Ophthalmology, New orleans, p.232, 2013
46. K.V. Chalam, MD, PhD, S. Gupta, MD, S. Grover,. Electronic tablet(I-Pad) improves reading ability as
well as quality of life of patients with poor vision secondary to macular degeneration. American
Academy of Ophthalmology, New orleans, p.232, 2013

41 05/07/16
47. K.Koushan, R Rusovici, K.V. Chalam. Proliferating retinal vascular endothelial cells are more sensitive
to bevacizumab than choroidal endothelial cells. Proceedings of 31st Annual Meeting of American
Society of Retina Specialists, 2013, Toronto
48. K.V. Chalam, K.Koushan, W Li, S Balaiya. Effect of distance and duration of illumination from a
surgical endoilluminator on retinal cells exposed to varying doses of brilliant blue green. Proceedings
of 31st Annual Meeting of American Society of Retina Specialists, 2013, Toronto
49. K.Koushan, K.V. Chalam. Miniaturized high resolution (HR) wide field contact lens for panretinal
photocoagulation. Proceedings of 31st Annual Meeting of American Society of Retina Specialists,
2013, Toronto
50. S Balaiya, Grant MB, KV Chalam. Influence of diabetic retinopathy aqueous in causing defective
CD34 cells. Association for Research in Vision and Ophthalmology, Seattle, Washington.
2013:274/ D223
51. R Bouhenni, DP Edward, S Grover, KV Chalam, AL Sewell, K Abu-amero. The aqueous humor
proteome in patients with diabetic retinopathy. Association for Research in Vision and
Ophthalmology, Seattle, Washington. 2013:1155/ D53
52. L Ferguson, S Grover, KV Chalam. Evaluation of spontaneous differentiation of hESCs into RPEs in
the absence of BFGF.Influence of diabetic retinopathy aqueous in causing defective CD34 cells.
Association for Research in Vision and Ophthalmology, Seattle, Washington. 2013:2211/A80
53. R Keshavamurthy, J Koh, S Chen, KV Chalam. Quantitative proteomics of vitreous humor to identify
potential markers in the induction of posterior vitreous detachment. Association for Research in
Vision and Ophthalmology, Seattle, Washington. 2013:3306/ B194
54. KV Chalam, W Li, S Balaiya. Evaluation ofBrilliant blue green (BBG) toxicity on retinal ganglion cells
exposed to varying levels of illumination with surgical metal halide endoilluminator. Association for
Research in Vision and Ophthalmology, Seattle, Washington. 2013:5773/ D23
55. K.V. Chalam. Safety and efficacy of anti=VGF drug therapy. International Society of Ocular
Pharmacology and Theraupeutics, 2013, Paris, France, P.53
56. Chalam KV. Biology of VEGF and implications in clinical practice. Proceedings of Asia Pacific
Ophthalmic Society, Hyderabad, India, 2013, p422
57. Chalam KV. Lenticular meridional astigmatism secondary to renal metastasis: a challenging case.
Proceedings of Asia Pacific Ophthalmic Society, Hyderabad, India, 2013, p812
58. Chalam KV. Rationale of DRCR.net intravitreal Anti-VEGF treatment and follow up of center involved
DME. Proceedings of Asia Pacific Ophthalmic Society, Hyderabad, India, 2013, p812
59. S. Grover, MD , M. Diaz, MD, L. Ferguson, MD, K.V. Chalam, MD, PhD . Retinal function by
microperimetry correlates with macular volume by spectral domain OCT. American Academy of
Ophthalmology, Chicago, p.232, 2012

42 05/07/16
60. S. Gupta, MD , S Balaiya, PhD, K.V. Chalam, MD, PhD . Aqueous interleukin-6 is superior to VEGF
as biomarker in monitoring therapeutic response in wetmacular degeneration. American Academy of
Ophthalmology, Chicago, p.235, 2012
61. K.V. Chalam, MD, PhD, D. Davis, MD, S. Grover, MD. Modified portable digital camera (Pictor) is as
effective as traditional nonmydriatic fundus camera for teleretinal screening of retinal disorders.
American Academy of Ophthalmology, Chicago, p.235, 2012
62. S. Gupta, MD , S. Grover, MD, K.V. Chalam, MD, PhD . Photoreceptor outer segment length on ultra
high resolution spectral domain OCT accurately predicts visual acuity recovery after macular surgery.
American Academy of Ophthalmology, Chicago, p.235, 2012
63. K.V. Chalam, MD, PhD , R.K. Murthy, S. Gupta, MD ,. Change in macular volume (Spectral Domain
OCT) is superior to macular thickness in predicting functional recovery in diabetic macular edema in
diabetic macular edema after anti VEGP therapy.. American Academy of Ophthalmology, Chicago,
p.236, 2012
64. Raluca Rusovici, Chirag Patel, K.V. Chalam. Effect of Bevacizumab on Cell Cycle of VEGF- Enriched
Proliferating Choroidal Endothelial Cells. Association for Research in Vision and Ophthalmology,
Ft.Lauderdale, Fl. 2012:788/A665
65. Joshua C. Priluck, K V. Chalam, Sandeep Grover. Macular Volume Change By Sectral-domain
Optical Coherence Tomography After Treatment With Bevacizumab in Exudative Macular
Degeneration. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl.
2012:801/D739
66. Shailesh K. Gupta, Ivana Obradovic, Rena Cappelli, Natalie McKee, Joshua Priluck, K V. Chalam,
Sandeep Grover.Evaluation of Fundus Images Using the New Hand-held 'Pictor' Camera..
Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:3107/D1236
67. Michelle Diaz, Ravi Kevashamurthy, K V. Chalam, Sandeep Grover. Normative Data for Macular
Volume by Spectral-Domain Optical Coherence Tomography (Spectralis). Association for Research
in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:4075/D1163
68. Kavitha Ravi, Ravi Keshavamurthy, S Balaiya, K V. Chalam. Dose Response Study Of Cytoprotective
Effect By Lutein And Zeaxanthin On Retinal Pigment Epithelium From Oxidative Stress Induced
Cytotoxicity. Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl.
20122:4755/A430
69. Lee R. Ferguson, KV. Chalam. Evaluation of Retinal Thickness with Customized Spectral Domain
Optical Coherence Tomography (SD-OCT) in Normal Mice. Association for Research in Vision and
Ophthalmology, Ft.Lauderdale, Fl. 2012:5000/D1011
70. Chirag J. Patel, K.V. Chalam, Sandeep Grover, Ravi Keshavamurthy, Joshua C. Priluck. Aqueous
Interleukin-6 (IL-6) Levels Are Superior To Vascular Endothelial Growth Factor (VEGF) Levels In

43 05/07/16
Predicting Therapeutic Response To Bevacizumab In Age-Related Macular Degeneration (AMD).
Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:5175/D1228
71. Carolee M. Cutler Peck, Raluca Rusovici, Sandeep Grover, K V. Chalam. Evaluation Of Cytotoxicity
Of Bevacizumab On VEGF-enriched Corneal Endothelial Cells. Association for Research in Vision
and Ophthalmology, Ft.Lauderdale, Fl. 2012:6002/D823
72. Ivana V. OBRADOVIC, Rena Cappelli, Joshua C. Priluck, K V. Chalam, Sandeep Grover. Comparison
of Color Vision Testing By Standard Ishihara Color Plates Versus iPad Version. Association for
Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:6394/A84
73. Wassia A. Khaja, Amy Kelmenson, K V. Chalam, Sandeep GroverComparison of Central Corneal
Thickness: Slit Lamp-OCT versus Ultrasound Pachymetry, Specular Microscopy, and Orbscan.
Association for Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:108/A251
74. V. Khetpal, S. Balaiya, KV Chalam. Inhibitory role of Resveratrolin the proliferation of choroidal
endothelial cells under hypoxic stress.Association for Research in Vision and Ophthalmology,
Ft.Lauderdale, Fl. 2012:442/D1119
75. KV Chalam,S. Balaiya, R Malyapa. Differential sensitivity of cultured mature retinal cells
(staurosphorine differentiated retinal ganglion cells and retinal pigment epithelial cells) against
proliferating choroidal endothelial cells to proton radiation.Association for Research in Vision and
Ophthalmology, Ft.Lauderdale, Fl. 2012:5564/D1191
76. Don K Davis, S.Balaiya, KV Chalam, Sandeep Grover. Neuroprotective role of sirtuin (SIRT1) against
hypoxia in Retinal ganglion cells. Association for Research in Vision and Ophthalmology,
Ft.Lauderdale, Fl. 2012:1958/A651
77. R.K. Murthy, S Balaiya, Tatiana McLauchlan, KV Chalam. In vitro cytotoxic effects of Brilliant Blue
Green (BBG) on retinal pigment epithelial cells after metal halide illumination.Association for
Research in Vision and Ophthalmology, Ft.Lauderdale, Fl. 2012:3791/A257
78. S. Balaiya, K.V. Chalam. Regulation of hypoxia mediated toxicity by a post-transcriptional regulator,
SIRT1 in choroidal neovascularization. International Society of Ocular Toxicology, 2011; Portland,
Oregon
79. S. Balaiya, K.V. Chalam. Protective role of sirtuin against hypoxia induced neurotoxicity. .
International Society of Ocular Toxicology, 2011; Portland, Oregon
80. KV Chalam, S. Balaiya, RS Malyapa. Proton beam radiation selectively destroys proliferating
chorodial endothelial cells and preserves non-proliferating retinal pigment epithelial cells: a model for
choroidal neovascular membrane.International Society of Ocular Toxicology. 2011; Portland,
Oregon
81. Tatiana McLauchlan, S Balaiya, KV Chalam. In vitro cytotoxic effects of Brilliant Blue Green (BBG) on
retinal pigment epithelial cells after metal halide illumination.International Society of Ocular
Toxicology. 2011; Portland, Oregon

44 05/07/16
82. K.V. Chalam, MD, PhD, V.Khetpal, MD, S. Gupta, MD, S. Grover, MD, . Navigated laser vs traditional
argon green modified grid photocoagulation for diffuse diabetic macular edema American Academy
of Ophthalmology, Orlando, p.222, 2011
83. K.V. Chalam, MD, PhD,S. Gupta, MD, S. Grover, MD, Evaluation of the impact of Ipad (as a low
visual aid) on reading ability and quality of life of low vision patients. American Academy of
Ophthalmology, Orlando, p.228, 2011
84. S. Balaiya, V.Khetpal, K.V. Chalam. Hypoxia induces a post-transcriptional regulator, SIRT1 (Histone
deactylase; HDAC) mediated VEGF activation in choroidal retinal neovascularisation.Proceedings of
29th Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.84
85. K.V. Chalam,V.Khetpal,S. Balaiya,. Resveretrol inhibits proliferation od choroidal endothelial cells in
hypoxia: a model for neovascular AMD.Proceedings of 29th Annual Meeting of American Society
of Retina Specialists, 2011, Boston, p.86
86. K.V. Chalam, V.Khetpal, R.Radhakrishnan. Newly designed miniaturized light weight wide angle
contact lens for digital fluorescien angiographic evaluation of retinal ischemia.Proceedings of 29th
Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.139
87. V.Khetpal, R.Radhakrishnan, R.K. Murthy,K.V. Chalam. Evaluation of a novel contactautomated focal
laser with integrated (NAVILAS) fluorescien angiography for diabetic macular edema.Proceedings of
29th Annual Meeting of American Society of Retina Specialists, 2011, Boston, p.141
88. V.Khetpal, R.Radhakrishnan, K.V. Chalam. Ultra wide angle fluoroscien angiography revealed
peripheral retinal ischemia correlates with retinal thinning in asymptomatic sickle cell
patients.Proceedings of 29th Annual Meeting of American Society of Retina Specialists, 2011,
Boston, p.156
89. R.Radhakrishnan, J.Edwards, V.Khetpal, K.V. Chalam. SD-OCT and infrared imaging of leukemic
infiltration of the choroid.Proceedings of 29th Annual Meeting of American Society of Retina
Specialists, 2011, Boston, p.175
90. R. Radhakrishnan, K.V. Chalam, V.S. Brar, S. Gupta, V. Khetpal, R. Keshavamurthy, S. Grover.
Evaluation of the Use of Navigated Laser (NAVILAS) in the Treatment of Diabetic Macular Edema.
Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 2011,52: E-
594
91. R Keshavamurthy, VS Brar, KV Chalam. Lutein And Zeaxanthin Protect Retinal Pigment Epithelium
From Oxidative Stress Induced Cytotoxicity. Association for Research in Vision and
Ophthalmology, Fort Lauderdale, Florida, 2011, 52: E-4433
92. Rena Cappelli, Ravi Radhakrishnan, KV Chalam, Sandeep Grover. Spectral Domain Optical
Coherence Tomography Features of Retinal Astrocytoma.Association for Research in Vision and
Ophthalmology, Fort Lauderdale, Florida, 2011, 52: E-3697

1.1.16 master CV

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to 1.1.16 master CV

Similar to 1.1.16 master CV (20)

1.1.16 master CV